+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 46555

Chapter 46555 provides scholary research titles of which PDF Full Texts are available through EurekaMag.





Flynn, J.T.; Hoff, H., 1995:
Lipopolysaccharide induces time-dependent increases in prostaglandin H synthase-2 and cytosolic phospholipase A2 mRNA in cultured human microvessel-derived endothelial cells

Oeth, P.A.; Parry, G.C.; Kunsch, C.; Nantermet, P.; Rosen, C.A.; Mackman, N., 1994:
Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site

Hall, A.J.; Vos, H.L.; Bertina, R.M., 1998:
Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappaB nuclear translocation

Franchin, G.; Zybarth, G.; Dai, W.W.; Dubrovsky, L.; Reiling, N.; Schmidtmayerova, H.; Bukrinsky, M.; Sherry, B., 2000:
Lipopolysaccharide inhibits HIV-1 infection of monocyte- derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5

Manna, S.K.; Aggarwal, B.B., 1999:
Lipopolysaccharide inhibits TNF-induced apoptosis: role of nuclear factor-kappaB activation and reactive oxygen intermediates

Tulić, M.K.; Knight, D.A.; Holt, P.G.; Sly, P.D., 2001:
Lipopolysaccharide inhibits the late-phase response to allergen by altering nitric oxide synthase activity and interleukin-10

Barrios-Rodiles, M.; Tiraloche, G.; Chadee, K., 1999:
Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha

Pozzoli, G.; Costa, A.; Grimaldi, M.; Schettini, G.; Preziosi, P.; Grossman, A.; Navarra, P., 1994:
Lipopolysaccharide modulation of eicosanoid and corticotrophin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2 alpha and lack of effect of nerve growth factor

Brzozowski, T.; Konturek, P.C.; Sliwowski, Z.; Drozdowicz, D.; Pajdo, R.; Stachura, J.; Hahn, E.G.; Konturek, S.J., 1998:
Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide

Gao, C.; Kennedy, S.; Ponder, K.P., 2001:
Lipopolysaccharide potentiates the effect of hepatocyte growth factor upon replication in lung, thyroid, spleen, and colon in rats in vivo

Shimizu, M.; Tamamori-Adachi, M.; Arai, H.; Tabuchi, N.; Tanaka, H.; Sunamori, M., 2002:
Lipopolysaccharide pretreatment attenuates myocardial infarct size: A possible mechanism involving heat shock protein 70-inhibitory kappaBalpha complex and attenuation of nuclear factor kappaB

Suzuki, K.; Yamamoto, T.; Sato, A.; Murayama, T.; Amitani, R.; Yamamoto, K.; Kuze, F., 1993:
Lipopolysaccharide primes human alveolar macrophages for enhanced release of superoxide anion and leukotriene B4: self-limitations of the priming response with protein synthesis

Mwita, J.C.; Magafu, M.G.M.D.; Omech, B.; Dewhurst, M.J.; Mashalla, Y., 2017:
Anaemia, renal dysfunction and in-hospital outcomes in patients with heart failure in Botswana

Ingalls, R.R.; Heine, H.; Lien, E.; Yoshimura, A.; Golenbock, D., 1999:
Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors

Dikopoulos, N.; Weidenbach, H.; Adler, G.; Schmid, R.M., 2002:
Lipopolysaccharide represses cholesterol 7-alpha hydroxylase and induces binding activity to the bile acid response element II

Wang, B.; Cai, S.R.; Gao, C.; Sladek, F.M.; Ponder, K.P., 2001:
Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4 alpha in rat liver

Zheng, S.; Brown, M.C.; Taffet, S.M., 1993:
Lipopolysaccharide stimulates both nuclear localization of the nuclear factor kappa B 50-kDa subunit and loss of the 105-kDa precursor in RAW264 macrophage-like cells

Kurita-Ochiai, T.; Fukushima, K.; Ochiai, K., 1998:
Lipopolysaccharide stimulates butyric acid-induced apoptosis in human peripheral blood mononuclear cells

Fessler, M.B.; Malcolm, K.C.; Duncan, M.William.; Worthen, G.Scott., 2002:
Lipopolysaccharide stimulation of the human neutrophil: an analysis of changes in gene transcription and protein expression by oligonucleotide microarrays and proteomics

Li, S.; Wu, C.; Shi, Y.; Liu, C., 2001:
Lipopolysaccharide upregulates expression of CD14 gene and CD14 proteins of hepatocytes in rats

Krogfelt, K.A.; Licht, T.R.; Molin, S., 1996:
Lipopolysaccharide's role in the association of Salmonella cells to the mouse intestine studied by ribosomal in situ hybridization

Borowski, T.; Kokkinidis, L.; Merali, Z.; Anisman, H., 1999:
Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia

Dieter, P.; Hempel, U.; Malessa, B.; Fitzke, E.; Tran-Thi, T.A.; MacLouf, J.; Créminon, C.; Kanaoka, Y.; Urade, Y., 2000:
Lipopolysaccharide- and liposome-encapsulated MTP-PE-induced formation of eicosanoids, nitric oxide and tumor necrosis factor-alpha in macrophages

De Laurentiis, A.; Pisera, D.; Caruso, C.; Candolfi, M.; Mohn, C.; Rettori, V.; Seilicovich, A., 2002:
Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis

Schumann, R.R.; Latz, E., 1999:
Lipopolysaccharide-binding protein

Kaden, J.; Zwerenz, P.; Lambrecht, H-G.; Dostatni, R., 2002:
Lipopolysaccharide-binding protein as a new and reliable infection marker after kidney transplantation

Koizumi, N.; Morozumi, A.; Imamura, M.; Tanaka, E.; Iwahana, H.; Sato, R., 1997:
Lipopolysaccharide-binding proteins and their involvement in the bacterial clearance from the hemolymph of the silkworm Bombyx mori

Salomao, R.; Brunialti, M.K.C.; Kallás, E.G.; Martins, P.S.; Rigato, O.; Freudenberg, M., 2003:
Lipopolysaccharide-cell interaction and induced cellular activation in whole blood of septic patients

de Eguileor, M.; Grimaldi, A.; Tettamanti, G.; Valvassori, R.; Cooper, E.L.; Lanzavecchia, G., 2001:
Lipopolysaccharide-dependent induction of leech leukocytes that cross-react with vertebrate cellular differentiation markers

Seki, E.; Tsutsui, H.; Nakano, H.; Tsuji, N.; Hoshino, K.; Adachi, O.; Adachi, K.; Futatsugi, S.; Kuida, K.; Takeuchi, O.; Okamura, H.; Fujimoto, J.; Akira, S.; Nakanishi, K., 2001:
Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta

Anderson, C.C.; Rahimpour, R.; Sinclair, N.R., 1994:
Lipopolysaccharide-induced IgM production is not suppressed by antigen receptor ligation in B cells from some autoimmune strains of mice

Schmidt, A.; Caron, E.; Hall, A., 2001:
Lipopolysaccharide-induced activation of beta2-integrin function in macrophages requires Irak kinase activity, p38 mitogen- activated protein kinase, and the Rap1 GTPase

Liang, X.; Qiao, Z.; Yin, L., 1999:
Lipopolysaccharide-induced apoptosis of rat hepatocyte in vitro

Islam, A.F.; Moss, N.D.; Dai, Y.; Smith, M.S.; Collins, A.M.; Jackson, G.D., 1999:
Lipopolysaccharide-induced biliary factors enhance invasion of Salmonella enteritidis in a rat model

Qin, M.F.; Wu, X.Z., 1993:
Lipopolysaccharide-induced cellular immunity response and effect of herbal purgation method in intra-abdominal infection

Jiang, S.; Naito, M.; Kaizu, C.; Kuwata, K.; Hasegawa, G.; Mukaida, N.; Shultz, L.D., 2001:
Lipopolysaccharide-induced cytokine and receptor expression and neutrophil infiltration in the liver of osteopetrosis (op/op) mutant mice

Amiot, F.; Fitting, C.; Tracey, K.J.; Cavaillon, J.M.; Dautry, F., 1998:
Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice

de Bont, E.S.; Niemarkt, A.E.; Tamminga, R.Y.; Kimpen, J.L.; Kamps, W.A.; de Leij, L.H., 1996:
Lipopolysaccharide-induced cytokine production in peripheral blood mononuclear cells: intracellular localization of tumor necrosis factor alpha and interleukin 1 beta detected with a three-color immunofluorescence technique

Forsythe, R.M.; Xu, D-Zhong.; Lu, Q.; Deitch, E.A., 2002:
Lipopolysaccharide-induced enterocyte-derived nitric oxide induces intestinal monolayer permeability in an autocrine fashion

Abate, A.; Oberle, S.; Schröder, H., 1999:
Lipopolysaccharide-induced expression of cyclooxygenase-2 in mouse macrophages is inhibited by chloromethylketones and a direct inhibitor of NF-kappa B translocation

O'Sullivan, M.G.; Huggins, E.M.; McCall, C.E., 1993:
Lipopolysaccharide-induced expression of prostaglandin H synthase-2 in alveolar macrophages is inhibited by dexamethasone but not by aspirin

Dial, E.J.; Romero, J.J.; Villa, X.; Mercer, D.W.; Lichtenberger, L.M., 2002:
Lipopolysaccharide-induced gastrointestinal injury in rats: role of surface hydrophobicity and bile salts

Knoetig, S.M.; McCullough, K.C.; Summerfield, A., 2001:
Lipopolysaccharide-induced impairment of classical swine fever virus infection in monocytic cells is sensitive to 2-aminopurine

Kamisaki, Y.; Wada, K.; Ataka, M.; Yamada, Y.; Nakamoto, K.; Ashida, K.; Kishimoto, Y., 1998:
Lipopolysaccharide-induced increase in plasma nitrotyrosine concentrations in rats

Richards, R.G.; Almond, G.W., 1994:
Lipopolysaccharide-induced increases in porcine serum cortisol and progesterone concentrations are not mediated solely by prostaglandin F2 alpha

Li, H.; Park, S.; Kilburn, B.; Jelinek, M.Anne.; Henschen-Edman, A.; Aswad, D.W.; Stallcup, M.R.; Laird-Offringa, I.A., 2002:
Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase

Nakamura, Y.; Si, Q.S.; Kataoka, K., 2000:
Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide

Danuser, B.; Rebsamen, H.; Weber, C.; Krueger, H., 2001:
Lipopolysaccharide-induced nasal cytokine response: a dose-response evaluation

Arcaroli, J.; Kupfner, J.; Yum, H-Kee.; Shenkar, R.; Park, J.Sung.; Abraham, E., 2002:
Lipopolysaccharide-induced neutrophil gene expression under in vivo or in vitro conditions

Ben-Shaul, V.; Sofer, Y.; Bergman, M.; Zurovsky, Y.; Grossman, S., 1999:
Lipopolysaccharide-induced oxidative stress in the liver: comparison between rat and rabbit

Webel, D.M.; Johnson, R.W.; Baker, D.H., 1999:
Lipopolysaccharide-induced reductions in body weight gain and feed intake do not reduce the efficiency of arginine utilization for whole-body protein accretion in the chick

Sundaram, R.; O'Connor, M.; Cicero, M.; Ghaffar, A.; Gangemi, J.D.; Mayer, E.P., 1993:
Lipopolysaccharide-induced suppression of erythrocyte binding and phagocytosis via Fc gamma RI, Fc gamma RII, Fc gamma RIII, and CR3 receptors in murine macrophages

Takashiba, S.; Van Dyke, T.E.; Shapira, L.; Amar, S., 1995:
Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor alpha promoter

Kato, Y.; Motoi, Y.; Taniai, K.; Kadono-Okuda, K.; Yamamoto, M.; Higashino, Y.; Shimabukuro, M.; Chowdhury, S.; Xu, J.; Sugiyama, M., 1994:
Lipopolysaccharide-lipophorin complex formation in insect hemolymph: a common pathway of lipopolysaccharide detoxification both in insects and in mammals

Jain, N.K.; Kulkarni, S.K.; Singh, A., 2002:
Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors

McKenna, T.M.; Fan, S.X.; Li, S., 1997:
Lipopolysaccharide-responsive protein kinase C isotypes in the adult rat aorta

Letournel-Boulland, M.L.; Fages, C.; Rolland, B.; Tardy, M., 1994:
Lipopolysaccharides (LPS), up-regulate the IL-1-mRNA and down-regulate the glial fibrillary acidic protein (GFAP) and glutamine synthetase (GS)-mRNAs in astroglial primary cultures

Tamura, M.; Chen, Y.J.; Howard, E.F.; Tanner, M.; Landon, E.J.; Myers, P.R., 2000:
Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts

de Cock, H.; Tommassen, J., 1996:
Lipopolysaccharides and divalent cations are involved in the formation of an assembly-competent intermediate of outer-membrane protein PhoE of E.coli

Gamian, A., 1996:
Lipopolysaccharides containing sialic acid

Girard, R.; Pedron, T.; Uematsu, S.; Balloy, V.; Chignard, M.; Akira, S.; Chaby, R., 2002:
Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2

Choma, A., 2003:
Lipopolysaccharides from Mesorhizobium huakuii and Mesorhizobium ciceri: chemical and immunological comparative data

Mathiak, G.; Kabir, K.; Grass, G.; Keller, H.; Steinringer, E.; Minor, T.; Rangger, C.; Neville, L.F., 2002:
Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays

Yoshimura, A.; Kaneko, T.; Kato, Y.; Golenbock, D.T.; Hara, Y., 2001:
Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4

Prendergast, M.M.; Moran, A.P., 2001:
Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies

Aspinall, G.O.; Monteiro, M.A.; Shaver, R.T.; Kurjanczyk, L.A.; Penner, J.L., 1997:
Lipopolysaccharides of Helicobacter pylori serogroups O:3 and O:6--structures of a class of lipopolysaccharides with reference to the location of oligomeric units of D-glycero-alpha-D-manno-heptose residues

Bersudsky, M.; Rosenberg, P.; Rudensky, B.; Wirguin, I., 2000:
Lipopolysaccharides of a Campylobacter coli isolate from a patient with Guillain-Barré syndrome display ganglioside mimicry

Molinaro, A.; D.C.stro, C.; Lanzetta, R.; Evidente, A.; Parrilli, M.; Holst, O., 2002:
Lipopolysaccharides possessing two L-glycero-D-manno-heptopyranosyl-alpha -(1-->5)-3-deoxy-D-manno-oct-2-ulopyranosonic acid moieties in the core region. The structure of the core region of the lipopolysaccharides from Burkholderia caryophylli

Yamaguchi, M.; Sawada, K.; Miyake, A., 1996:
Lipopolysaccharides selectively inhibit mouse placental lactogen-II secretion through stimulation of interleukin-1 alpha (IL-1 alpha) and IL-6 production

Nowicka, G., 1994:
Lipoprotein (A)--atherogenic factor

Musiał, J.; Undas, A.; Libura, M.; Scisło, K.; Kubicka, A., 1993:
Lipoprotein (A). Missing link in pathogenesis of atherosclerosis?

Ezhov, M.V.; Liakishev, A.A.; Pokrovskiĭ, S.N., 2001:
Lipoprotein (a) - an independent risk factor in atherosclerosis

Monnet, D.; Edjeme, N.E.; Ndri, K.; Hauhouot-Attoungbre, M.L.; Ahibo, H.; Sangare, A.; Yapo, A.E., 2002:
Lipoprotein (a) and acute phase inflammation proteins in homozygous sickle cell disease

Seriolo, B.; Accardo, S.; Fasciolo, D.; Sulli, A.; Bertolini, S.; Cutolo, M., 1995:
Lipoprotein (a) and anticardiolipin antibodies as risk factors for vascular disease in rheumatoid arthritis

Peng, D.Q.; Zhao, S.P.; Wang, J.L., 1999:
Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke

Farrace, S.; Biselli, R.; Urbani, L.; D.A.gelis, C., 1999:
Lipoprotein (a) and apoprotein B in an apparently healthy population of fighter pilots and ground personnel: their significance as potential markers of atherosclerosis

Schachter, M., 2000:
Lipoprotein (a) and cardiovascular risk

Kiortsis, D.N.; Evangelou, A.; Elisaf, M.S., 2001:
Lipoprotein (a) and chronic obstructive pulmonary disease

Rao, A., 2001:
Lipoprotein (a) and coronary heart diseases in Indian population

Taupin, J.M.; Durlach, V.; Hassaim, M.; Gillery, P.; Jolly, D.; Boirie, Y.; Grulet, H.; Leutenegger, M., 1993:
Lipoprotein (a) and diabetes: relationship based on 224 cases

Sánchez Bayle, M.; Baeza Mínguez, J.; Vila Dupla, S.; Arnaiz Rodríguez, P.; Martín Batanero, A.; Fernández Calle, M.; Antón Pacheco, E., 1999:
Lipoprotein (a) and family history in 6-year-old children from Rivas-Vaciamadrid

Cimminiello, C.; Soncini, M.; Gerosa, M.C.; Toschi, V.; Motta, A.; Bonfardeci, G., 1995:
Lipoprotein (a) and fibrinolytic system in liver cirrhosis. Coagulation Abnormalities in Liver Cirrhosis (CALC) Study Group

Lippi, G.; Guidi, G., 1998:
Lipoprotein (a) and ischaemic cerebrovascular disease

Britareva, V.V.; Afanas'eva, O.I.; Dobrovol'skiĭ, A.B.; Titaeva, E.V.; Karpov, I.A.; Pokrovskiĭ, S.N., 2002:
Lipoprotein (a) and ischemic heart disease in patients with hypertensive disease

Seishima, M.; Kirii, H.; Abe, A., 1999:
Lipoprotein (a) and its phenotype

Cheng, S.W.; Ting, A.C.; Wong, J., 1997 :
Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease

Isser, H.S.; Puri, V.K.; Narain, V.S.; Saran, R.K.; Dwivedi, S.K.; Singh, S., 2002:
Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their first-degree relatives

Noma, A., 1995:
Lipoprotein (a) and mid-band lipoprotein

Chi, J.; Tang, W.; Sun, M., 1996:
Lipoprotein (a) and non-insulin dependent diabetes mellitus

Huerva, Vín.; Puig, T.; Reche, J.Alberto., 2002:
Lipoprotein (a) and occlusions of retinal arterial

Danese, C.; Borgia, M.C.; Ferranti, E.; Zavattaro, E.; Epiceno, A.N.; Marcianó, F., 1996:
Lipoprotein (a) and plasminogen in atherosclerosis

Tomikawa, S.; Mezawa, M.; Yoshida, Y.; Saiga, T.; Shimizu, Y., 1993:
Lipoprotein (a) and sclerotic changes in retinal arterioles

Gaeta, G.; Cuomo, S.; Boeri, F.; Foglia, M.C.; Iovine, C.; Boccalatte, A., 1996:
Lipoprotein (a) and serum lipid levels young subjects with parents suffering from myocardial infarct

Hernández, C.; Chacón, P.; García-Pascual, L.; Rosselló, J.; Simó, R., 1999:
Lipoprotein (a) and the evaluation of low density cholesterol by the Friedewald formula: a new problem for an old equation

Lip, G.Y., 2001:
Lipoprotein (a) and thrombogenesis in left ventricular dysfunction

Schneider, R.; Yagil, Y., 1997:
Lipoprotein (a) as a cardiovascular risk factor in man

Batalla Celorio, A.; Julián Rodríguez Reguero, J.; Iglesias Cubero, G.; Hevia Nava, S.; Braga Fernández, S.; Fernández Bustillo, E.; Cortina Llosa, A., 2000:
Lipoprotein (a) as a predictor of severity of coronary artery stenosis documented by angiography in male coronary patients under 50 years old

Serdar, A.; Yeşilbursa, D.; Serdar, Z., 2002:
Lipoprotein (a) as a risk factor for coronary artery disease in women and elderly patients

Motta, M.; Giugno, I.; Ruello, P.; Pistone, G.; D.F.zio, I.; Malaguarnera, M., 2001:
Lipoprotein (a) behaviour in patients with hepatocellular carcinoma

Hassan, H.M.; Kohno, H.; Kuromaru, R.; Honda, S.; Ueda, K., 1995:
Lipoprotein (a) changes during growth hormone treatment

Shi, H.; Fang, J.; Yang, X.; Shen, Z.; Zhu, X., 2001:
Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus

Bairaktari, E.T.; Hatzidimou, K.; Elisaf, M.S., 1999:
Lipoprotein (a) concentrations in Greek hyperlipidaemic patients: relationship to serum lipid parameters

Vrhovski-Hebrang, D.; Flegar-Mestrić, Z.; Bobetić-Vranić, T.; Surina, B., 1999:
Lipoprotein (a) concentrations in school children and adolescents in Croatia

Straube, R.; Kingreen, H., 1999:
Lipoprotein (a) immunapheresis in the treatment of familial lipoprotein (a) hyperlipoproteinemia in a patient with coronary heart disease

Mooser, V., 2001:
Lipoprotein (a) in Alzheimer's atherosclerosis

Gürbüz, O.; Ozdemir, Y.; Coşar, C.B.; Kural, G., 2001:
Lipoprotein (a) in Behçet's disease as an indicator of disease activity and in thrombotic complications

Devanapalli, B.; Lee, S.; Mahajan, D.; Bermingham, M., 2002:
Lipoprotein (a) in an immigrant Indian population sample in Australia

Wassef, G.N., 2000:
Lipoprotein (a) in android obesity and NIDDM: a new member in 'the metabolic syndrome'

Zwolińska, D.; Kiliś-Pstrusińska, K.; Szprynger, K., 1998:
Lipoprotein (a) in children with chronic renal failure treated conservatively

Zwolińska, D.; Szprynger, K., 1997:
Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis

del Cura, J.; Gil-Paraiso, A.; Borque, L.; Carazo, M.E.; Maside, C.; Sánchez-Casajús, A., 1993:
Lipoprotein (a) in chronic renal failure patients undergoing hemodialysis: does it have an independent role in the development of further cardiovascular complications?

Yamamura, T.; Nomura, S.; Yang, X.; Toyota, Y.; Sonobe, M.; Yamamoto, A.; Haze, K.; Hiramori, K.; Hara, H.; Yamaguchi, T.; Pokrovsky, S.N., 1995:
Lipoprotein (a) in ischemic heart disease and cerebrovascular disease

Selvais, P.; Henrion, J.; Schapira, M.; Derue, G.; Hondekijn, J.C.; Parfonry, A.; Heller, F.R., 1995:
Lipoprotein (a) in liver diseases. Correlation between low levels and liver function

Franek, E.; Kokot, F., 1997:
Lipoprotein (a) in physiological states and kidney diseases

Edelberg, J.M.; Pizzo, S.V., 1995:
Lipoprotein (a) in the regulation of fibrinolysis

Sood, A.; Midha, V.; Sood, N.; Kaushal, V., 2000:
Lipoprotein (a) in ulcerative colitis

Ishikawa, H., 1994:
Lipoprotein (a) is a risk factor for cerebrovascular accident in patients with chronic renal failure

Cheng, S.W.; Ting, A.C., 2001:
Lipoprotein (a) level and mortality in patients with critical lower limb ischaemia

Lye, W.C.; Hughes, K.; Leong, S.O.; Lee, E.J., 1995:
Lipoprotein (a) levels and clinical correlations in CAPD patients

Scheer, W.D.; Boudreau, D.A.; Cook, C.B., 1996:
Lipoprotein (a) levels in African-Americans with NIDDM

Barbagallo, C.M.; Averna, M.R.; Sparacino, V.; Galione, A.; Caputo, F.; Scafidi, V.; Amato, S.; Mancino, C.; Cefalù, A.B.; Notarbartolo, A., 1993:
Lipoprotein (a) levels in end-stage renal failure and renal transplantation

Guindeo, C.; Vega, N.; Fernandez, A.M.; Palop, L.; Aguilar, J.A.; Moreda, A.; Cia, P., 1996:
Lipoprotein (a) levels in patients undergoing continuous ambulatory peritoneal dialysis

Geethanjali, F.S.; Jose, V.Jacob.; Kanagasabapathy, A.S., 2002:
Lipoprotein (a) phenotypes in south Indian patients with coronary artery disease

Edelberg, J.; Pizzo, S.V., 1994:
Lipoprotein (a) regulates plasmin generation and inhibition

Mondorf, U.F.; Piiper, A.; Herrero, M.; Bender, M.; Scheuermann, E.H.; Geiger, H., 1999:
Lipoprotein (a) stimulates mitogen activated protein kinase in human mesangial cells

Couderc, R.; Maachi, M., 1998:
Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice

Ariyo, A.; Hennekens, C.H.; Stampfer, M.J.; Ridker, P.M., 1999:
Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Health Study

van Bodegraven, A.A.; Meuwissen, S.G., 2001:
Lipoprotein (a), thrombophilia and inflammatory bowel disease

Rim, L.; Ali, B.; Slim, B.A.; Bechir, Z., 2001:
Lipoprotein (a). A new risk factor for coronary artery disease

Rocchini, A.P., 1999:
Lipoprotein (a): a controversial risk factor for atherosclerotic heart disease

Vaverková, H.; Novotný, D.; Ficker, L.; Vlachová, I.; Chudácková, J., 1993:
Lipoprotein (a): a genetic risk factor for early ischemic cerebrovascular stroke

Widmann, M.D.; Sumpio, B.E., 1993:
Lipoprotein (a): a risk factor for peripheral vascular disease

Enas, E.A.; Mehta, J.L., 1998:
Lipoprotein (a): an important risk factor in coronary artery disease

Ben Ammar, S.; Mrad, R.; Bahlous, A.; Lakdhar, R.; Ben Mansour, Y.; Boukhalfa, S.; Kachboura, S.; Belhani, A., 1998:
Lipoprotein (a): biochemical aspects and physiopathological variations

Cerioli, G.; Tirelli, F.; Bonetti, A., 1995:
Lipoprotein (a): effect of detraining

Nowak-Göttl, U.; Debus, O.; Findeisen, M.; Kassenböhmer, R.; Koch, H.G.; Pollmann, H.; Postler, C.; Weber, P.; Vielhaber, H., 1997:
Lipoprotein (a): its role in childhood thromboembolism

Jones, A.F.; Lip, G.Y., 1998:
Lipoprotein (a): more than just a bystander in the pathophysiology of hypertension?

Enríquez, L.; Matas, P., 2001:
Lipoprotein (a): physiopathology and clinical and therapeutic considerations

Edelberg, J.M.; Lee, Y.J.; Young, T.N.; Pizzo, S.V., 1993:
Lipoprotein (a): purification and kinetic analysis

Mohan, A.; Srinivasan, V.; Deepa, R.; Mohan, V., 2002:
Lipoprotein (a): role in diabetes and its vascular complications

Souza, D.R.; Garcia, M.V., 1994:
Lipoprotein (a): variability and association with coronary disease

Boman, L.; Ericson, M., 1997:
Lipoprotein A levels after intestinal bypass operation for morbid obesity

Koppaka, V.; Axelsen, P.H., 2000:
Lipoprotein A-I structure

Chapman, J.; Guérin, M., 1994:
Lipoprotein Lp(a) and CETP (cholesterol ester transfer protein): contribution of transgenic mice

de la Peña-Díaz, A.; Izaguirre-Avila, R.; Anglés-Cano, E., 2000:
Lipoprotein Lp(a) and atherothrombotic disease

Denti, L.; Marchini, L.; Pasolini, G.; Baffoni, M.T.; Ablondi, F.; Valenti, G., 1995:
Lipoprotein Lp(a) and cerebrovascular disease in the elderly: correlations with the severity of extracranial carotid atherosclerosis assessed by ultrasonography

Cremer, P.; Nagel, D.; Labrot, B.; Mann, H.; Muche, R.; Elster, H.; Seidel, D., 1994:
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)

Seishima, M.; Hua, F., 2001:
Lipoprotein X

van den Ende, A.; van der Hoek, Y.Y.; Kastelein, J.J.; Koschinsky, M.L.; Labeur, C.; Rosseneu, M., 1996:
Lipoprotein [a

Chin, C.; Rosenthal, D.; Bernstein, D., 2000:
Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients

Fernández-Miranda, C.; de la Calle, A.; Morales, J.M.; Guijarro, C.; Aranda, J.L.; Gómez-Sanz, R.; Gómez-Izquierdo, T.; Larumbe, S.; Moreno, E.; Rodicio, J.L.; del Palacio, A., 1998:
Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study

Murakami, T.; Yamada, N.; Kawakubo, K.; Oku, J.; Mizushima, Y.; Iino, S.; Sugimoto, T., 1997:
Lipoprotein abnormalities in non-insulin dependent diabetic patients with ischemic heart disease

Yoshino, G.; Hirano, T.; Kazumi, T., 1997:
Lipoprotein abnormalities in normolipidemic diabetics

Cengiz, K.; Bakan, A.; Yilmaz, H., 2002:
Lipoprotein abnormalities in patients with secondary renal amyloidosis

Murakami, T.; Urata, T.; Yamada, N.; Kawakubo, K.; Yoshida, T.; Kawamura, H.; Kashiwa, T.; Iino, S., 1997:
Lipoprotein abnormalities in type 2 diabetic patients. Increased distribution of triglycerides (TG) in very low density lipoprotein (VLDL) and decreased apolipoprotein E/VLDL-TG ratio are risk for ischemic heart disease

Kawakubo, K.; Lee, J.S., 2001:
Lipoprotein abnormality in obesity

Neyrolles, O.; Gould, K.; Gares, M.P.; Brett, S.; Janssen, R.; O'Gaora, P.; Herrmann, J.L.; Prévost, M.C.; Perret, E.; Thole, J.E.; Young, D., 2000:
Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria

Mohan, P.F., 1997:
Lipoprotein activated macrophages in co-culture with mesangial and endothelial cells: nitric oxide and tissue injury

Colyar, M.R., 2002:
Lipoprotein analysis

Ito, Y., 1994:
Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice

Kido, T.; Kurata, H.; Matsumoto, A.; Tobiyama, R.; Musha, T.; Hayashi, K.; Tamai, S.; Utsunomiya, K.; Tajima, N.; Fidge, N.; Itakura, H.; Kondo, K., 2001:
Lipoprotein analysis using agarose gel electrophoresis and differential staining of lipids

Arndt, T.; Pelzer, M.; Nenoff, P.; Pelzer, S.; Lindeke, A.; Steinmetz, A.; Haustein, U.F., 2000:
Lipoprotein and apolipoprotein electrophoresis in X-chromosome recessive ichthyosis

Rudel, L.L.; Parks, J.S.; Hedrick, C.C.; Thomas, M.; Williford, K., 1999:
Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids

Itakura, H., 1995:
Lipoprotein and lipoprotein fractions

Itakura, H., 1999:
Lipoprotein and lipoprotein subfractions

Sapian-Raczkowska, B.; Adamiec, R.; Zdrojowy, K.; Masłowski, L., 1999:
Lipoprotein and plasminogen serum levels in patients with diabetes mellitus type 2: risk factors for macroangiopathy? Preliminary study

Keréveur, A.; Cambillau, M.; Kazatchkine, M.; Moatti, N., 1996:
Lipoprotein anomalies in HIV infections

Edwards, K.L.; Talmud, P.J.; Newman, B.; Krauss, R.M.; Austin, M.A., 2001:
Lipoprotein candidate genes for multivariate factors of the insulin resistance syndrome: a sib-pair linkage analysis in women twins

Batalla, A.; Hevia, S.; Sieres, M.; Raviña, Tás., 2002:
Lipoprotein changes during acute coronary syndromes

Fernández-Miranda, C.; Castellano, G.; Guijarro, C.; Fernández, I.; Schöebel, N.; Larumbe, S.; Gómez-Izquierdo, T.; del Palacio, A., 1998:
Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha

Stein, E.A.; Black, D.M., 2002:
Lipoprotein changes with statins

Kruth, H.S., 2002:
Lipoprotein cholesterol and atherosclerosis

Véniant, M.M.; Zlot, C.H.; Walzem, R.L.; Pierotti, V.; Driscoll, R.; Dichek, D.; Herz, J.; Young, S.G., 1998:
Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice

Goff, D.C.; D'Agostino, R.B.; Haffner, S.M.; Saad, M.F.; Wagenknecht, L.E., 2000:
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study

Rainwater, D.L., 1999:
Lipoprotein correlates of LDL particle size

James, R.W.; Brulhart-Meynet, M.C.; Lehmann, T.; Golay, A., 1998:
Lipoprotein distribution and composition in obesity: their association with central adiposity

Djamali, A.; Cristol, J.P.; Turc-Baron, C.; Beucler, I.; Baldet, P.; Mourad, G., 1996:
Lipoprotein glomerulopathy: a new French case with recurrence on the transplant

Andrews, P.A., 1999:
Lipoprotein glomerulopathy: a new cause of nephrotic syndrome after renal transplantation. Implications for renal transplantation

Karet, F.E.; Lifton, R.P., 1997:
Lipoprotein glomerulopathy: a new role for apolipoprotein E?

Zhang, P.; Matalon, R.; Kaplan, L.; Kumar, A.; Gallo, G., 1994:
Lipoprotein glomerulopathy: first report in a Chinese male

Actis Dato, S.M.; Rebolledo, O.R., 2001:
Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus

Packard, C.J.; Shepherd, J., 1998:
Lipoprotein heterogeneity and apolipoprotein B metabolism

Casanueva, V.; Cid, X.; Calvo, C.; Chiang, M.T.; Ulloa, N.; Milos, C.; Rodríguez, W.; Elgueta, F., 1996:
Lipoprotein in children and adolescents: relationship with family history of coronary artery disease

Enright, P.L.; Lasser, E.C.; Ward, B.J.; Tracy, R.P., 1996:
Lipoprotein levels in elderly patients with asthma. Cardiovascular Health Study Research Group

Sass, C.; Herbeth, B.; Siest, G.; Visvikis, S., 2001:
Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort

Skoczyńska, A., 1998:
Lipoprotein lipase (LPL) in the pathogenesis of atherosclerosis

Hocquette, J.F.; Graulet, B.; Olivecrona, T., 1999:
Lipoprotein lipase activity and mRNA levels in bovine tissues

Katamoto, H.; Aoki, M.; Shimada, Y.; Hakogi, E., 1995:
Lipoprotein lipase activity of post-heparin plasma in Japanese black cattle affected with fat necrosis

Rodríguez, V.M.; Macarulla, M.T.; Chávarri, M.; Durán, D.; Portillo, M.P., 2002:
Lipoprotein lipase and lipogenic enzyme activities in adipose tissue from rats fed different lipid sources

Fielding, B.A.; Frayn, K.N., 1999:
Lipoprotein lipase and the disposition of dietary fatty acids

Pillarisetti, S.; Saxena, U., 2002:
Lipoprotein lipase as a therapeutic target for dyslipidemia

Sasaki, A.; Sivaram, P.; Goldberg, I.J., 1993:
Lipoprotein lipase binding to adipocytes: evidence for the presence of a heparin-sensitive binding protein

Ikeda, Y.; Takagi, A., 2001:
Lipoprotein lipase deficiency, familial

Pérez, F.; Lafayette, T.; Santos, J.L.; Calivillán, M.; Carrasco, E., 1998:
Lipoprotein lipase gene polymorphism in non-insulin-dependent diabetics: preliminary study

Jemaa, R.; Fumeron, F.; Poirier, O.; Lecerf, L.; Evans, A.; Arveiler, D.; Luc, G.; Cambou, J.P.; Bard, J.M.; Fruchart, J.C., 1995:
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde

Fumeron, F.; Jemaa, R.; Poirier, O.; Cambien, F.; Tiret, L., 1998:
Lipoprotein lipase gene variants and coronary risk

Chappell, D.A.; Fry, G.L.; Waknitz, M.A.; Muhonen, L.E.; Pladet, M.W.; Iverius, P.H.; Strickland, D.K., 1993:
Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans

Kihara, S., 1998:
Lipoprotein lipase inhibitory factor

Medh, J.D.; Fry, G.L.; Bowen, S.L.; Ruben, S.; Wong, H.; Chappell, D.A., 2000:
Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism

van Barlingen, H.H.; Kleinveld, H.A.; Erkelens, D.W.; de Bruin, T.W., 1997:
Lipoprotein lipase-enhanced binding of lipoprotein(a) [Lp(a)] to heparan sulfate is improved by apolipoprotein E (apoE) saturation: secretion-capture process of apoE is a possible route for the catabolism of Lp(a)

Bruckert, E.; Dejager, S., 1994:
Lipoprotein lipase: a key enzyme of lipid metabolism

Foubert, L.; Benlian, P.; Turpin, G., 1996:
Lipoprotein lipase: a multifunctional enzyme in lipoprotein metabolism

Kovalenko, I.G.; Bershteĭn, L.M., 1996:
Lipoprotein lipase: properties, change in activity with age and in some noninfectious human diseases

Huff, M.W.; Telford, D.E.; Edmonds, B.W.; McDonald, C.G.; Evans, A.J., 1993:
Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil

Maitra, A.; Meherji, P.K.; Desai, M.P.; Gokral, J.S.; Donde, U.M.; Joshi, U.M., 1994:
Lipoprotein lipids in androgen excess--a study among Indian women

Wu, X.; Zhang, Z.; Su, Y., 2000:
Lipoprotein lipids in polycystic ovarian syndrome: independent associations with androgen excess and insulin resistance

Wilson, P.W., 2001:
Lipoprotein measurements--setting priorities

Berndt, B.; Mensink, G.B.; Kohlmeier, M.; Kohlmeier, L.; Köttgen, E., 1993:
Lipoprotein metabolism and coffee intake--who is at risk?

Attman, P.O.; Samuelsson, O.; Alaupovic, P., 1993:
Lipoprotein metabolism and renal failure

Renke, M.; Zdrojewski, Z., 1998:
Lipoprotein metabolism disturbances in patients with kidney diseases

Arai, Y.; Hirose, N.; Nakazawa, S.; Yamamura, K.; Shimizu, K.; Takayama, M.; Ebihara, Y.; Osono, Y.; Homma, S., 2002:
Lipoprotein metabolism in Japanese centenarians: effects of apolipoprotein E polymorphism and nutritional status

Gaeta, G.; Effuso, L.; Maurea, N.; Boccalatte, M.; Scala, R.; Sifola, C.; Antignano, A., 1994:
Lipoprotein metabolism in arterial walls and its relationship with the genesis of atheromatous lesion

Goldberg, I.J., 1993:
Lipoprotein metabolism in normal and uremic patients

Reaven, P.D.; Napoli, C.; Merat, S.; Witztumc, J.L., 2000:
Lipoprotein modification and atherosclerosis in aging

Pillarisetti, S., 2001:
Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity

Muzia, G.I.; Kulikov, V.I.; Ponomareva, I.V.; Sukhikh, G.T., 1999:
Lipoprotein oxidation in the blood of women with pregnancy complications

van de Vijver, L.P.; Kardinaal, A.F.; Grobbee, D.E.; Princen, H.M.; van Poppel, G., 1998:
Lipoprotein oxidation, antioxidants and cardiovascular risk: epidemiologic evidence

Calvo, C.; Olmos, A.; Ulloa, N.; Bustos, A.; Toledo, L.; Durán, D.; Naveas, R., 2000 :
Lipoprotein particles LpA-I, LpA-I: A-II and LpB in coronary artery disease

Banyai-Falger, S.; Gottsauner-Wolf, M.; Stepan, E.; Strobl, W.; Jansen, M.; Heinz, G.; Hörl, W.H.; Derfler, K., 1997:
Lipoprotein pattern in end-stage renal disease and following successful renal transplantation

Gunby, P., 1996:
Lipoprotein patterns, plaque, homocysteine, and hormones among ongoing cardiology studies

Offidani, A.M.; Ferretti, G.; Taus, M.; Simonetti, O.; Dousset, N.; Valdiguie, P.; Curatola, G.; Bossi, G., 1994:
Lipoprotein peroxidation in adult psoriatic patients

Joles, J.A.; Willekes-Koolschijn, N.; Scheek, L.M.; Koomans, H.A.; Rabelink, T.J.; van Tol, A., 1994:
Lipoprotein phospholipid composition and LCAT activity in nephrotic and analbuminemic rats

Busnach, G., 1998:
Lipoprotein plasmapheresis

Nielsen, L.B., 2003:
Lipoprotein production by the heart: a novel pathway of triglyceride export from cardiomyocytes

Sarría Chueca, A.; Martín Nasarre de Letosa, M.T.; Lomba García, B.; Moreno Aznar, L.A.; Lázaro Almarza, A.; Bueno Sánchez, M., 1998:
Lipoprotein profile determinants in children and adolescents from a lipid consultation clinic. The impact of diet, body composition and physical activity

López Martínez, D.; Gil, A.; Porres, A.; Blázquez, E.; Montoya, T.; Vivanco, F.; Alvarez-Sala, L.; Gómez Gerique, J.A.; de Oya, M., 1996:
Lipoprotein profile in children and adolescents of the Autonomous Community of Madrid

Uzuner, N.; Karaman, O.; Saydam, N.; Güner, G., 2002:
Lipoprotein profile in long term theophylline administration in children with asthma

Zuliani, G.; Ble', A.; Zanca, R.; Munari, M.R.; Zurlo, A.; Vavalle, C.; Atti, A.R.; Fellin, R., 2002:
Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease

Tinahones, F.J.; C-Soriguer, F.J.; González-Ruiz, A.; Ruano, T.J.; Pareja, A.; Collantes, E., 1996:
Lipoprotein profile in patients with isolated hyperuricemia

Djessou, P.; Kakou, A.R.; Camara, C.M.; N'ko, M.; Tiahou, G.; Mansour, A.F.; Bissagnene, E.; Sess, E.D., 1999:
Lipoprotein profile of patients infected with HIV in Côte d'Ivoire

Giada, F.; Zuliani, G.; Baldo-Enzi, G.; Palmieri, E.; Volpato, S.; Vitale, E.; Magnanini, P.; Colozzi, A.; Vecchiet, L.; Fellin, R., 1996:
Lipoprotein profile, diet and body composition in athletes practicing mixed an anaerobic activities

Ebbesson, S.O.; Schraer, C.; Nobmann, E.D.; Ebbesson, L.O., 1996:
Lipoprotein profiles in Alaskan Siberian Yupik Eskimos

Rudling, M.; Gåfvels, M.; Parini, P.; Gahrton, G.; Angelin, B., 1998:
Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation

Hermann, M.; Mahon, M.G.; Lindstedt, K.A.; Nimpf, J.; Schneider, W.J., 2000:
Lipoprotein receptors in extraembryonic tissues of the chicken

Robenek, H.; Severs, N.J., 1993:
Lipoprotein receptors on macrophages and smooth muscle cells

Ducobu, J., 1997:
Lipoprotein receptors. Old acquaintances and newcomers

Smith, W.Grady.; Wang, J.; Dang, A.; Reeves, C.; Bibbs, D.; Faas, F.H., 2001:
Lipoprotein susceptibility to oxidation in the macromolecular fraction of plasma: relation to plasma lipids and oleate/linoleate ratio in comparison with whole plasma in hypertriglyceridemia

Pauciullo, P., 2002:
Lipoprotein transport and metabolism: a brief update

Fonseca, I.; Queirós, J.; Costa, S.; Santos, M.J.; Henriques, A.C.; Sarmento, A.M.; Guimarães, S.; Pereira, M., 2002:
Lipoprotein(A) in renal transplant recipients

Noto, D.; Barbagallo, C.M.; Cavera, G.; Caldarella, R.; Marino, G.; Pace, A.; Notarbartolo, A.; Averna, M.R., 1999:
Lipoprotein(A) levels and apoprotein(a) phenotypes in a Sicilian population

Pursiainen, M., 1993:
Lipoprotein(A), a unique atherogenic lipoprotein, review on the literature and methodology

Tomita, S.; Ishibashi, S., 2001:
Lipoprotein(a) [Lp(a)]

Feussner, G.; Feussner, V.; Ziegler, R., 1994:
Lipoprotein(a) [Lp(a)]--a genetically related risk factor for arteriosclerosis

Jonasson, L.; Eriksson, T.; Dahle'n, G.H.; Lindblom, B., 1997:
Lipoprotein(a) and HLA-DRB1 and -DQB1 genes in coronary artery disease

Seriolo, B.; Accardo, S.; Cutolo, M., 1996:
Lipoprotein(a) and anticardiolipin antibodies as risk factors for thrombotic events in polymyalgia rheumatica and giant cell arteritis

Kim, S.B.; Yang, W.S.; Kang, E.S.; Min, W.K.; Park, J.S., 1997:
Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease

Sniderman, A.D., 2002:
Lipoprotein(a) and atherogenesis: a puzzle inside a riddle within an enigma

Spada, R.S.; Ferri, R.; Mangiafico, R.A.; Roccasalva, G.; Toscano, G.; D.C.taldo, V.; Santonocito, M., 1999:
Lipoprotein(a) and atheromatous disease of epiaortic arterial trunks in the very old

Earle, K.A.; Mattock, M.; Morocutti, A.; Aravanitis, D.; Viberti, G.C., 1996:
Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate

Cardoso-Saldaña, G.; Ize-Lema, I.; Kimura, L.Y.; Zamora González, J.; Posadas Romero, C., 1997:
Lipoprotein(a) and cardiovascular risk in adult Mexicans

Dahlén, G.H.; Weinehall, L.; Stenlund, H.; Jansson, J.H.; Hallmans, G.; Huhtasaari, F.; Wall, S., 1998:
Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case-control study from Sweden

Singh, S.; Dwivedi, S.; Melkani, G.C.; Rani, C.; Gaur, S.P.; Mandal, S.K.; Mahua, J., 2001:
Lipoprotein(a) and coronary heart disease in Indian population

Marcovina, S.M.; Hegele, R.A.; Koschinsky, M.L., 2000:
Lipoprotein(a) and coronary heart disease risk

Wehinger, A.; Kastrati, A.; Elezi, S.; Baum, H.; Braun, S.; Neumann, F.J.; Schömig, A., 1999:
Lipoprotein(a) and coronary thrombosis and restenosis after stent placement

Haffner, S.M., 1993 :
Lipoprotein(a) and diabetes. An update

Stein, D.; Schoebel, F.C.; Leschke, M., 1996:
Lipoprotein(a) and hemostasis-activation markers in angina pectoris

Gruden, G.; Veglio, M.; Cavallo-Perin, P.; Olivetti, C.; Mormile, A.; Cassader, M.; Pagano, G., 1994:
Lipoprotein(a) and insulin treatment in NIDDM patients

Howard, G.C.; Pizzo, S.V., 1993:
Lipoprotein(a) and its role in atherothrombotic disease

Farrell, R.J., 1993:
Lipoprotein(a) and its role in occlusive vascular disease

Ochoa-Sosa, C.A.; Mondragón-Rodríguez, G.; Zamora-González, J.; Cardoso-Saldaña, G.; Herrera-Acosta, J.; Posadas-Romero, C., 1998:
Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant

Vella, J.C.; Calmarza, P., 1998:
Lipoprotein(a) and other lipid parameters in cord blood: a study of 528 cases

Becerra, A.; Bellido, D.; Luengo, A.; Piédrola, G.; D.L.is, D.A., 1999:
Lipoprotein(a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapy

Seriolo, B.; Accardo, S.; Cutolo, M., 1996:
Lipoprotein(a) and other risk factors for thrombosis in rheumatoid arthritis

Heinimann, K.; Stähelin, H.B.; Perrig-Chiello, P.; Perrig, W.O.; Ehrsam, R.; Meier, B.; Krings, F., 1996:
Lipoprotein(a) and plasma lipids in 429 elderly and very old subjects: significance as risk factor, effect of nutrition and life style

Boemi, M.; Sirolla, C.; Amadio, L.; Fumelli, P.; James, R.W., 1997:
Lipoprotein(a) and retinopathy in IDDM and NIDDM patients

Ritter, M.M.; Geiss, H.C.; Richter, W.O.; Schwandt, P., 1994:
Lipoprotein(a) and risk of myocardial infarction

Ridker, P.M.; Hennekens, C.H., 1994:
Lipoprotein(a) and risks of cardiovascular disease

Scanu, A.M., 2003:
Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications

Pedro-Botet, J.; Sentí, M., 1994:
Lipoprotein(a) and the cardiovascular risk

Porcelli, A.; Calleri, L.; Gallello, D.; Taccani, C.; Surico, N., 1997:
Lipoprotein(a) and the cardiovascular risk during estrogen-progestin replacement therapy in postmenopause

Wityk, R.J.; Kittner, S., 2000:
Lipoprotein(a) and the risk of stroke

Ezhov, M.V.; Afanas'ev, O.I.; Benevolenskaia, G.F.; Savchenko, A.P.; Liakishev, A.A.; Pokrovskiĭ, S.N., 1997:
Lipoprotein(a) as a biochemical marker of coronary atherosclerosis

Murakami, K.; Ishibashi, S.; Yoshida, Y.; Yamada, N.; Akanuma, Y., 1998:
Lipoprotein(a) as a coronary risk factor in Japanese patients with Type II (non-insulin-dependent) diabetes mellitus. Relation with apolipoprotein(a) phenotypes

Schreiner, P.J.; Chambless, L.E.; Brown, S.A.; Watson, R.L.; Toole, J.; Heiss, G., 1994:
Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities

Enas, E.A., 1998:
Lipoprotein(a) as a determinant of coronary heart disease in young women: a stronger risk factor than diabetes?

Duriez, P.; Dallongeville, J.; Fruchart, J.C., 1996:
Lipoprotein(a) as a marker for coronary heart disease

Naito, H.K.; Kwak, Y.S., 1990:
Lipoprotein(a) as a new biochemical marker for assessment of coronary heart disease risk

Marcovina, S.M.; Koschinsky, M.L., 1999:
Lipoprotein(a) as a risk factor for coronary artery disease

Lenzi, S.; Scanu, A.; D.C.terina, R., 1996:
Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms

Gambhir, J.K.; Kaur, H.; Gambhir, D.S.; Prabhu, K.M., 2000:
Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age

Foody, J.M.; Milberg, J.A.; Pearce, G.L.; Sprecher, D.L., 2001:
Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis

Marcovina, S.M.; Koschinsky, M.L., 1999:
Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis?

Elisaf, M.; Siamopoulos, K.C., 1996:
Lipoprotein(a) concentration in patients with renal diseases

Alberty, R., 1994:
Lipoprotein(a) concentration in various hyperlipidemias

Maser, R.E.; Usher, D.; Becker, D.J.; Drash, A.L.; Kuller, L.H.; Orchard, T.J., 1993:
Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort

Shimura, Y.; Tanaka, T.; Ohtani, H., 1997:
Lipoprotein(a) concentrations and apolipoprotein(a) phenotype frequencies in cord blood of newborn infants and sera of children in Japan

Graziani, M.S.; Zanolla, L.; Righetti, G.; Nicoli, M.; Modena, N.; Dimitri, G.; Menegatti, G.; Vassanelli, C., 1993:
Lipoprotein(a) concentrations are increased in patients with myocardial infarction and angiographically normal coronary arteries

Yang, C.W.; Kim, Y.S.; Kim, S.Y.; Choi, E.J.; Chang, Y.S.; Yoon, Y.S.; Bang, B.K.; Koh, Y.B., 1994:
Lipoprotein(a) concentrations in chronic renal failure and following renal transplantation

Wood, W.G.; Schumacher, M., 1995:
Lipoprotein(a) concentrations in non-selected hospitalised patients between 18 and 100 years of age: comparison with cholesterol fractions and triacylglycerols in patients with lipid status requests

Figueroa, A.C.; Gil, R.L.; Pedragós, A.C.; González, G.C.; Marqués, R.B.; Díaz, J.A.; Llanos, J.O.; Pérez, A.P., 1996:
Lipoprotein(a) concentrations in type I diabetes mellitus

van Pampus, M.G.; Koopman, M.M.; Wolf, H.; Büller, H.R.; Prins, M.H.; van den Ende, A., 1999:
Lipoprotein(a) concentrations in women with a history of severe preeclampsia--a case control study

Han, Y.S.; Ueda, M.; Tanabe, S.; Nakatani, T.; Kishimoto, T.; Suzuki, S.; Amemiya, H.; Kimura, J., 1998:
Lipoprotein(a) deposition is associated with the development of transplant renal arteriosclerosis in humans

Marcovina, S.M.; Lippi, G.; Guidi, G., 1995:
Lipoprotein(a) immunoassays: comparison of a semi-quantitative latex method and two monoclonal enzyme immunoassays

Deepa, R.; Mohan, A.; Rema, M.; Haranath, S.P.; Saravanan, G.; Mohan, V., 2002:
Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications

Maffei, P.; Sicolo, N.; Plebani, M., 1999:
Lipoprotein(a) in acromegaly

Lip, G.Y., 2000:
Lipoprotein(a) in atrial fibrillation

Nomura, S., 1995:
Lipoprotein(a) in cerebrovascular and coronary atherosclerosis

Sánchez Bayle, M.; Baeza Mínguez, J.; Vila Dupla, S.; Ruiz-Jarabo Quemada, C.; Asensio Antón, J.; Arnaiz, P.; Martín, F., 1996:
Lipoprotein(a) in children with hypercholesterolemia as a marker of the familial history of cardiovascular risk. The Working Group on Cardiovascular Risk Factors in Childhood and Adolescence

Malaguarnera, M.; Giugno, I.; Trovato, B.A.; Panebianco, M.P.; Restuccia, N.; Ruello, P., 1996:
Lipoprotein(a) in cirrhosis. A new index of liver functions?

Gurewich, V.; Mittleman, M., 1994:
Lipoprotein(a) in coronary heart disease. Is it a risk factor after all?

Gupta, R.; Kastia, S.; Rastogi, S.; Kaul, V.; Nagar, R.; Enas, E.A., 2000:
Lipoprotein(a) in coronary heart disease: a case-control study

Velho, G.; Erlich, D.; Turpin, E.; Néel, D.; Cohen, D.; Froguel, P.; Passa, P., 1993:
Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM

Byrne, C.D.; Wild, S.H., 1994:
Lipoprotein(a) in health and disease

Papagrigorakis, E.; Iliopoulos, D.; Asimacopoulos, P.J.; Safi, H.J.; Weilbaecher, D.J.; Ghazzaly, K.G.; Nava, M.L.; Gaubatz, J.W.; Morrisett, J.D., 1998:
Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm

Kronenberg, F.; Utermann, G.; Dieplinger, H., 1996:
Lipoprotein(a) in renal disease

Popkova, T.V.; Pokrovskiĭ, S.N.; Alekberova, Z.S.; Reshetniak, T.M.; Fomicheva, O.A.; Aleksandrova, E.N.; Kliukvina, N.G.; Nasonov, E.L., 1998:
Lipoprotein(a) in systemic lupus erythematosus

Groop, P.H.; Viberti, G.C.; Elliott, T.G.; Friedman, R.; Mackie, A.; Ehnholm, C.; Jauhiainen, M.; Taskinen, M.R., 1994:
Lipoprotein(a) in type 1 diabetic patients with renal disease

Muga, R.; Llobet, P.; Tor, J.; Rey-Joly, C., 1995:
Lipoprotein(a) increase in intravenous drug addicts with HIV(+) infection

Mohan, V.; Deepa, R.; Haranath, S.P.; Premalatha, G.; Rema, M.; Sastry, N.G.; Enas, E.A., 1998:
Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India

Simons, L.; Friedlander, Y.; Simons, J.; McCallum, J., 1993:
Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study

Tian, H.; Han, L.; Ren, Y.; Li, X.; Liang, J., 2002:
Lipoprotein(a) level and lipids in type 2 diabetic patients and their normoglycemic first-degree relatives in type 2 diabetic pedigrees

Ishikawa, S.; Deguchi, T.; Hara, K.; Takuma, S.; Kayaba, K.; Tsutsumi, A.; Kario, K.; Igarashi, M., 1999:
Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors

Litofsky, N.Scott.; Miller, D.C.; Chen, Z.; Simonyi, A.; Klakotskaia, D.; Giritharan, A.; Feng, Q.; McConnell, D.; Cui, J.; Gu, Z., 2018:
Anaemia worsens early functional outcome after traumatic brain injury: a preliminary study

Estellés, A.; Cano, A.; Falcó, C.; España, F.; Gilabert, J.; Grancha, S.; Aznar, J., 1999:
Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause--influence of hormone replacement therapy

Nagashima, K.; Yutani, S.; Miyake, H.; Onigata, K.; Yagi, H.; Kuroume, T., 1993:
Lipoprotein(a) levels in Japanese children with IDDM

Torres-Tamayo, M.; Zamora-González, J.; Bravo-Ríos, L.E.; Cardoso-Saldaña, G.; Mendoza-Morfín, F.; Posadas-Romero, C., 1998:
Lipoprotein(a) levels in children and adolescents with diabetes

Pulzer, F.; Haase, U.; Kratzsch, J.; Richter, V.; Rassoul, F.; Kiess, W.; Keller, E., 2000:
Lipoprotein(a) levels in formerly small-for-gestational-age children

Miltiadous, G.; Tsimihodimos, V.; Bairaktari, E.; Elisaf, M., 2001:
Lipoprotein(a) levels in patients with homozygous familial hypercholesterolaemia

Martínez-Triguero, M.L.; Artero, A.; Vicente, R.; Molina, E., 1996:
Lipoprotein(a) levels in patients with human immunodeficiency virus infection

Urakami, K.; Wada-Isoe, K.; Wakutani, Y.; Ikeda, K.; Ji, Y.; Yamagata, K.; Kowa, H.; Okada, A.; Adachi, Y.; Nakashima, K., 2000:
Lipoprotein(a) phenotypes in patients with vascular dementia

Gazzaruso, C.; Buscaglia, P.; Garzaniti, A.; Bonetti, G.; Savino, S.; Mariotti, S.; Jucci, A.; Finardi, G.; Geroldi, D., 1996:
Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension

Zuliani, G.; Bader, G.; Imbastaro, T.; Mezzetti, A.; Taddeo, U.; Kostner, G.M.; Fellin, R., 1995:
Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo-nonagenarians. Associazione Medica Sabin

Bostom, A.G., 1994:
Lipoprotein(a) risk in women and efficacy of ascorbate

Pantoni, L.; Sarti, C.; Pracucci, G.; D.C.rlo, A.; Vanni, P.; Inzitari, D., 2001:
Lipoprotein(a) serum levels and vascular diseases in an older Caucasian population cohort. Italian Longitudinal Study on Aging (ILSA)

Agewall, S.; Fagerberg, Börn., 2002:
Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men

Payne, M.N.; Bartlett, W.A.; McDonald, F.; Murray, R.G.; Beattie, J.M.; Jones, A.F., 1995:
Lipoprotein(a), ACE, and family history of CAD

Scanu, A.M., 2001:
Lipoprotein(a), Friedewald formula, and NCEP guidelines. National Cholesterol Education Program

Fortmann, S.P.; Marcovina, S.M., 1997:
Lipoprotein(a), a clinically elusive lipoprotein particle

Akita, H.; Chiba, H.; Noritake, M.; Katsura, Y.; Udo, Y.; Shibuya, H.; Hui, S.P.; Takahashi, Y.; Nagasaka, H., 1996:
Lipoprotein(a), apolipoprotein(a) phenotypes, and nephropathy in NIDDM patients

Seman, L.J.; McNamara, J.R.; Schaefer, E.J., 1999:
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factors

Dahl, T.; Kontny, F.; Slagsvold, C.E.; Christophersen, B.; Abildgaard, U.; Odegaard, O.R.; Morkrid, L.; Dale, J., 2000:
Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolism

Pandolfi, C.; Pellegrini, L.; Dedè, A.; L.V.cchio, M.; Mercantini, F., 1997:
Lipoprotein(a), parameters of lipid metabolism and hemostasis in obese patients

Harpel, P.C.; Hermann, A.; Zhang, X.; Ostfeld, I.; Borth, W., 1995:
Lipoprotein(a), plasmin modulation, and atherogenesis

Serrano, M.; de Irala, J.; Palacios, M., 2001:
Lipoprotein(a), tobacco use, and risk of coronary heart disease

Oravec, S.; Oravec, D.; Dieplinger, H., 1998:
Lipoprotein(a)--a risk factor for coronary sclerosis in patients with hypothyroidism

Kronenberg, F.; Utermann, G., 1994:
Lipoprotein(a)--atherogenic waste product of evolution?

Dincić, D.; Jovicić, A.; Prcović, M., 1998:
Lipoprotein(a)--possible role in the fibrinolysis process

Campos, E., 1997:
Lipoprotein(a). Its importance as an additional atherosclerosis marker

Martínez, M.T.; Pérez, F.; Calvillán, M.; Gutiérrez-López, M.D.; Serrano Ríos, M., 1994:
Lipoprotein(a). Its relationship with atherosclerosis and diabetes

Hansen, P.R., 1993:
Lipoprotein(a): a link between thrombosis and atherosclerosis?

Belo, Lís.; Caslake, M.; Santos-Silva, A.; Pereira-Leite, Lís.; Quintanilha, A.; Rebelo, I., 2002:
Lipoprotein(a): a longitudinal versus a cross-sectional study in normal pregnancy and its levels in preeclampsia

Lasunción, M.A.; Alvarez, J.J.; Herrera, E., 1993:
Lipoprotein(a): from hidden pre-beta lipoprotein to cardiovascular risk factor

Guazzelli, R.; Fatini, C.; Piazzini, M.; Lazzeri, C., 1996:
Lipoprotein(a): genetic marker of precocious myocardial infarction

Scanu, A.M.; Atzeni, M.M.; Edelstein, C.; Tonolo, G.; Maioli, M.; Klezovitch, O., 1998:
Lipoprotein(a): identification of subjects with a superbinding capacity for fibrinogen

Simons, L.A., 1993:
Lipoprotein(a): important risk factor or passing fashion?

Hobbs, H.H.; White, A.L., 1999:
Lipoprotein(a): intrigues and insights

Nachman, R.L., 1997:
Lipoprotein(a): molecular mischief in the microvasculature

Couderc, R.; Maachi, M., 1999:
Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice

Harpel, P.C.; Poon, M.; Zhang, X.; Taubman, M.B., 1995:
Lipoprotein(a): searching for a function

Dieplinger, H., 2000:
Lipoprotein(a): the really bad cholesterol?

Wieringa, G., 2000:
Lipoprotein(a): what's in a measure?

Enas, E.A., 2001:
Lipoprotein(a)is an important genetic risk for coronary artery disease in Asian Indians

Seishima, M., 1995:
Lipoprotein-X (LP-X)

Edwards, C.M.; Otal, M.P.; Stacpoole, P.W., 1993:
Lipoprotein-X fails to inhibit hydroxymethylglutaryl coenzyme A reductase in HepG2 cells

Lynn, E.G.; Siow, Y.L.; Frohlich, J.; Cheung, G.T.; O.K., 2001:
Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B

Cassader, M.; Ruiu, G.; Gambino, R.; Alemanno, N.; Triolo, G.; Veglia, F.; Pagano, G., 2003:
Lipoprotein-apolipoprotein changes in renal transplant recipients

Packard, C.J.; O'Reilly, D.S.; Caslake, M.J.; McMahon, A.D.; Ford, I.; Cooney, J.; Macphee, C.H.; Suckling, K.E.; Krishna, M.; Wilkinson, F.E.; Rumley, A.; Lowe, G.D., 2000:
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

Suckling, K.E.; Macphee, C.H., 2002:
Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque

Hegele, R.A.; Ban, M.R.; Busch, C.P.; Ramsewak, S.; Ramdath, D.D., 2000:
Lipoprotein-genotype associations in Trinidadian neonates

Sushamabai, S.; Subrahmanian, D., 1998:
Lipoprotein-lipase deficiency

Utreja, S.; Khopade, A.J.; Jain, N.K., 1999:
Lipoprotein-mimicking biovectorized systems for methotrexate delivery

Schreiner, P.J.; Morrisett, J.D.; Sharrett, A.R.; Patsch, W.; Tyroler, H.A.; Wu, K.; Heiss, G., 1993:
Lipoprotein[a] as a risk factor for preclinical atherosclerosis

Doucet, C.; Huby, T.; Chapman, J.; Thillet, J., 1994:
Lipoprotein[a] in the chimpanezee: relationship of apo[a] phenotype to elevated plasma Lp[a] levels

van der Hoek, Y.Y.; Wanders, R.J.; van den Ende, A.E.; Kraft, H.G.; Gabel, B.R.; Kastelein, J.J.; Koschinsky, M.L., 1997:
Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disorders

Kottke, B.A., 1994:
Lipoproteins and apolipoproteins. Making use of their metabolic properties to individualize therapy

Strong, J.P.; Zieske, A.W.; Malcom, G.T., 2002:
Lipoproteins and atherosclerosis in children: an early marriage?

Cullen, P.; Funke, H.; Schulte, H.; Assmann, G., 1998:
Lipoproteins and cardiovascular risk--from genetics to CHD prevention

Cullen, P.; Funke, H.; Schulte, H.; Assmann, G., 1997:
Lipoproteins and cardiovascular risk-from genetics to CHD prevention

Johnson, W.J.; Phillips, M.C.; Rothblat, G.H., 1997:
Lipoproteins and cellular cholesterol homeostasis

Zahouani, A.; Fricker, J.; Girard-Globa, A., 1996:
Lipoproteins and cholesterol ester transfer protein in obese women on a very low calorie diet

Bertsch, T.; Aufenanger, J., 1998:
Lipoproteins and diabetic nephropathy

Owens, D.; Collins, P.B.; Johnson, A.; Tomkin, G.H., 2000:
Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate

Pang, C.P.; Baum, L., 2000:
Lipoproteins and related molecules in Alzheimer's disease

Barth, J.D., 1995:
Lipoproteins and the progression/regression of atherosclerosis

Wanner, C., 2000:
Lipoproteins and vascular changes in chronic kidney failure

Titov, V.N., 1997:
Lipoproteins as functional associates of protein-lipid complexes (literature review)

Fruchart, J.C., 1994:
Lipoproteins containing apolipoprotein A-I and reverse transport of cholesterol

Véniant, M.M.; Nielsen, L.B.; Borén, J.; Young, S.G., 1999:
Lipoproteins containing apolipoprotein B-100 are secreted by the heart

Kuriyama, M., 1999:
Lipoproteins in clinical laboratory medicine

Frayn, 2000:
Lipoproteins in health and disease

Hobbs, C.G.; Kodikara, M.; Gray, R.; Bordin, P.; Robinson, A.; Pacy, P.J.; Venkatesan, S.; Halliday, D., 1996:
Lipoproteins in non-insulin dependent diabetes mellitus (NIDDM)

Garin, C.F.; Heras, H.; Pollero, R.J., 1996:
Lipoproteins of the egg perivitelline fluid of Pomacea canaliculata snails (Mollusca: Gastropoda)

Janeway, C.A.; Medzhitov, R., 1999:
Lipoproteins take their toll on the host

Seriolo, B.; Accardo, S.; Fasciolo, D.; Bertolini, S.; Cutolo, M., 1996:
Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis

Cheng, H.M., 1996:
Lipoproteins, anticardiolipin autoantibodies and artherosclerosis

Guimarães, A.C., 1995:
Lipoproteins, antioxidants, and coronary cardiopathy

Siegel, R.D.; Cupples, A.; Schaefer, E.J.; Wilson, P.W., 1996:
Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study

Hensley, W.J.; Mansfield, C.H., 1999:
Lipoproteins, atherogenicity, age and risk of myocardial infarction

Mansfield, C.H., 2000:
Lipoproteins, diabeto-genicity, age and risk of diabetes mellitus death

Tóth, I.E.; Szabö, D.; Bruckner, G.G., 1997:
Lipoproteins, lipid droplets, lysosomes, and adrenocortical steroid hormone synthesis: morphological studies

Serban, M.G.; Negru, T., 2000:
Lipoproteins, lipidic peroxidation and total antioxidant capacity in serum of aged subjects suffering from hyperglycemia

Feingold, K.R.; Grunfeld, C., 1997:
Lipoproteins: are they important components of host defense?

Jaitely, V.; Kanaujia, P.; Vyas, S.P., 1997:
Lipoproteins: their potential as endogenous target oriented novel drug delivery system

Sattler, G.; Sommer, B., 2001:
Liporecycling: a technique for facial rejuvenation and body contouring

Tamura, B.M.; Odo, M.Y.; Chichierchio, A.L.; Cucé, L.C., 2001:
Liporeduction by endocoagulation

Davidova, S.Y.; Shapot, V.S., 1970:
Liporibonucleoprotein complex as an integral part of animal cell plasma membranes

Matsumoto, K.; Hukuda, S.; Ishizawa, M.; Egawa, M.; Okabe, H., 2000:
Liposarcoma associated with multiple intramuscular lipomas. A case report

Stephensen, S.L.; Schwarz Lausten, G.; Thomsen, H.S.; Bjerregaard, B., 1999:
Liposarcoma in association with total hip replacement

Harder, D.; Schmuziger, N., 2000:
Liposarcoma in the area of the head-neck

Zheng, J.W.; Wang, Y., 1994:
Liposarcoma in the oral and maxillofacial region: an analysis of 10 consecutive patients

Arkun, R.; Memis, A.; Akalin, T.; Ustun, E.E.; Sabah, D.; Kandiloglu, G., 1997:
Liposarcoma of soft tissue: MRI findings with pathologic correlation

Diekmann, F.; Rudolph, B.; Winzer, K.J.; Bick, U., 1999:
Liposarcoma of the breast arising within a phyllodes tumor

Mazaki, T.; Tanak, T.; Suenaga, Y.; Tomioka, K.; Takayama, T., 2002:
Liposarcoma of the breast: a case report and review of the literature

Parks, R.W.; Mullan, F.J.; Kamel, H.M.; Walsh, M.Y.; McKelvey, S.T., 1994:
Liposarcoma of the colon

Nakahara, H.; Shirasuna, K.; Terada, K., 1994:
Liposarcoma of the floor of the mouth: a case report

van der Stegen, D.; Lefort, T.; Mosnier, J.F.; Soulhiard, F.; Seguin, P.; Beziat, J.L., 1994:
Liposarcoma of the head

Wambeek, N.D.; Mendelson, R.M., 1996:
Liposarcoma of the hypopharynx

Mouret, P., 1999:
Liposarcoma of the hypopharynx. A case report and review of the literature

Acharki, A.; Sahraoui, S.; Benider, A.; Samlali, R.; Kahlain, A., 1999:
Liposarcoma of the larynx. Review of the literature apropos of a case

Ghosh, A.; Das, S.; Sengupta, K.; Majumdar, S., 2000:
Liposarcoma of the mediastinum--a rare cause of haemorrhagic pleural effusion

Gialdini, F.; Frezza, D.; Alaggio, R.; Biscaro, G., 1995:
Liposarcoma of the oral cavity: description of a case and review of the literature

Cockerham, K.P.; Kennerdell, J.S.; Celin, S.E.; Fechter, H.P., 1998:
Liposarcoma of the orbit: a management challenge

Dündar, M.; Erol, H.; Koçak, I.; Kaçar, F., 2001:
Liposarcoma of the spermatic cord

Cecchi, M.; Fiorentini, L.; Pagni, G.L.; Filardo, A.; Arganini, M.; Lombardi, M., 1998:
Liposarcoma of the spermatic cord. Clinical case

Ferrozzi, F.; Chiari, G.; Draghi, F., 1993:
Liposarcoma of the spermatic cord. Description of a case

Gastaldi, E.; Benvenuti, S.; Iacoviello, M.; Mennini, B.; Caviglione, M.; Traverso, G.B., 1994:
Liposarcoma of the spermatic cord: a clinical case

Soler Soler, J.L.; Zuluaga Gómez, A.; Hidalgo Domínguez, M.R.; Bados Nieto, M.P.; Martínez Torres, J.L.; de la Fuente Serrano, A.; Nogueras Ocaña, M., 1999:
Liposarcoma of the spermatic cord: a report of a new case and a review of the literature

Farhat, F.; Kattan, J.; Culine, S.; Théodore, C.; Terrier-Lacombe, M.J.; Génin, J.; Mounedji-Boudiaf, L.; Bekradda, M.; Droz, J.P., 1994:
Liposarcoma of the spermatic cord: apropos of a case with review of the literature

Mordi, A.; Batoko, A.; Delteil, C., 2000:
Liposarcoma of the thigh: 20-year development

Fujioka, T.; Suzuki, Y.; Ohori, M., 1997:
Liposarcoma, lipoma and lipomatosis of the kidney

Wong, C.K.; Edwards, A.T.; Rees, B.I., 1999:
Liposarcoma: a review of current diagnosis and management

Weiss, S.W., 1999:
Liposarcoma: an update

Grimer, R.J.; Carter, S.R.; Tillman, R.M.; Mangham, D.C., 1998:
Liposarcoma: diagnosis and management

Dei Tos, A.P., 2000:
Liposarcoma: new entities and evolving concepts

Gilkey, F.W., 1993:
Liposclerosing myxofibrous tumor of bone

Valeriani, M.; Mezzana, P.; Madonna Terracina, F.S., 2001:
Liposculpture and lipofilling of the gluteal-trochanteric region: anatomical analysis and technique

Ren, Z.Y., 1993:
Liposculpture by syringe technique

Alexander, R.W., 2002:
Liposculpture of the cervicofacial region

Goodstein, W.A.; Hoefflin, S.M., 1993:
Liposculpture sans suction

Mealer, W.R., 1996:
Liposculpture with the nasal Fraser suction techniques

Bruno, G.; Amadei, F.; Abbiati, G., 1998:
Liposculpture with ultrasound: biomedical considerations

Fischer, G., 1998:
Liposculpture. My technique

Felicio, 1993:
Liposculpturing by Syringe Technique in Obesity

Goodstein, W.A., 1998:
Liposhaver in facial plastic surgery

Muroi, M.; Kimura, K.; Osada, H.; Inukai, M.; Takatsuki, A., 1997:
Liposidomycin B inhibits in vitro formation of polyprenyl (pyro)phosphate N-acetylglucosamine, an intermediate in glycoconjugate biosynthesis

Benz, S.; Pfeffer, F.; Büsing, M.; Clemens, M.R.; Waladkhani, A.; Becker, H.D.; Hopt, U.T., 1996:
Liposoluble antioxidants are not consumed in the pancreas after reperfusion in human simultaneous pancreas-kidney transplantation

Lawrence, S.M.; Alpar, H.O.; McAllister, S.M.; Brown, M.R., 1993:
Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge and drug association

Frankenberger, M.; Hofmann, B.; Emmerich, B.; Nerl, C.; Schwendener, R.A.; Ziegler-Heitbrock, H.W., 1997:
Liposomal 1,25 (OH)2 vitamin D3 compounds block proliferation and induce differentiation in myelomonocytic leukaemia cells

Meye, A.; Würl, P.; Löhn, M.; Lasch, J.; Bache, M.; Hinze, R.; Holzhausen, H.J.; Schmidt, H.; Rath, F.W.; Taubert, H., 1999:
Liposomal DNA transfection of human sarcoma cells with p53 alterations

Anonymous, 1996:
Liposomal KS drugs approved

Gano, J.B.; Kleinerman, E.S., 1994:
Liposomal MTP-PE

Gilbert, B.E., 1997:
Liposomal aerosols in the management of pulmonary infections

Sundar, S., 2001:
Liposomal amphotericin B

Inselmann, G.; Schimanski, A.; Jahns, R.; Heidemann, H.T., 1999:
Liposomal amphotericin B (AmBisome) application and hepatic microsomal enzyme function in the rat

Leenders, A.C.; de Marie, S.; ten Kate, M.T.; Bakker-Woudenberg, I.A.; Verbrugh, H.A., 1996:
Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis

Merhav, H.; Nakache, R.; Houri, I.; Orni-Wasserlauf, R., 2001:
Liposomal amphotericin B (Ambisome) is safe and effective in the treatment of invasive mycosis in organ transplant patients

Böhme, A.; Hoelzer, D., 1996:
Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients

Borrelli, P.; Imperato, A.; Murdaca, G.; Scudeletti, M., 2000:
Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV

Walsh, T.J.; Finberg, R.W.; Arndt, C.; Hiemenz, J.; Schwartz, C.; Bodensteiner, D.; Pappas, P.; Seibel, N.; Greenberg, R.N.; Dummer, S.; Schuster, M.; Holcenberg, J.S., 1999:
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

Prentice, H.G.; Kibbler, C.C., 1999:
Liposomal amphotericin B for fever and neutropenia

Uhlenbrock, S.; Zimmermann, M.; Fegeler, W.; Jürgens, H.; Ritter, J., 2002:
Liposomal amphotericin B for prophylaxis of invasive fungal infections in high-risk paediatric patients with chemotherapy-related neutropenia: interim analysis of a prospective study

Michaud, D., 2002:
Liposomal amphotericin B for the treatment of severe fungal infection

Anonymous, 2001:
Liposomal amphotericin B found safe and effective

Baquero Artigao, F.; Salas Hernández, S.; Quero Jiménez, J., 1996:
Liposomal amphotericin B in the treatment of systemic fungal infection in the neonate. The results of one case

Anonymous, 2001:
Liposomal amphotericin B indicated for empirical therapy

Hay, R.J., 1994:
Liposomal amphotericin B, AmBisome

Stöckler, S.; Lackner, H.; Ginter, G.; Schwinger, W.; Plecko, B.; Müller, W., 1993:
Liposomal amphotericin-B (AmBisome) for treatment of cutaneous widespread candidosis in an infant with methylmalonic acidaemia

Mantadakis, E.; Kamen, B., 1999:
Liposomal anthracyclines for brain tumors

Fan, J.; Shek, P.N.; Suntres, Z.E.; Li, Y.H.; Oreopoulos, G.D.; Rotstein, O.D., 2000:
Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome

Arndt, D.; Zeisig, R.; Bechtel, D.; Fichtner, I., 2001:
Liposomal bleomycin: increased therapeutic activity and decreased pulmonary toxicity in mice

Harrington, K.J., 2002:
Liposomal cancer chemotherapy: current clinical applications and future prospects

Soltes, S.; Mustard, R.A.; Shek, P.N.; Florio, E.; Bohnen, J.M.; Mittelman, M.W., 1995:
Liposomal cefoxitin in a porcine model of intra-abdominal sepsis: bactericidal efficacy

Soltes, S.; Shek, P.N.; Mustard, R.A.; Soric, I.; Bohnen, J.M.; Mittelman, M.W., 1996:
Liposomal cefoxitin in a porcine model of intra-abdominal sepsis: hemodynamic changes

Smart, T., 1995:
Liposomal chemotherapies

Jordan, M.B.; van Rooijen, N.; Izui, S.; Kappler, J.; Marrack, P., 2002:
Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model

McBride, N.C.; Cavenagh, J.D.; Ward, M.C.; Grant, I.; Schey, S.; Gray, A.; Hughes, A.; Mills, M.J.; Cervi, P.; Newland, A.C.; Kelsey, S.M., 2001:
Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma

Pivnik, A.V.; Shtroiakovskiĭ, D.L.; Medvedev, P.V.; Moiseeva, T.N.; Shklovskiĭ-Kordi, N.E.; Skorokhod, A.A., 1999:
Liposomal daunorubicin (daunosom) in the treatment of recurrent acute promyelocytic leukemia

Savchenko, V.G.; Parovichnikova, E.N.; Isaev, V.G.; Shuravina, E.N.; Demidova, I.A.; Ol'shanskaia, I.V., 2002:
Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia

Money-Kyrle, J.F.; Bates, F.; Ready, J.; Gazzard, B.G.; Phillips, R.H.; Boag, F.C., 1993:
Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study

Tulpule, A.; Rarick, M.U.; Kolitz, J.; Bernstein, J.; Myers, A.; Buchanan, L.A.; Espina, B.M.; Traynor, A.; Letzer, J.; Justice, G.R.; McDonald, D.; Roberts, L.; Boswell, W.; Nathwani, B.; Levine, A.M., 2001:
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma

Anonymous, 1996:
Liposomal daunorubicin marketed for HIV-related Kaposi's sarcoma

Pratt, G.; Wiles, M.E.; Rawstron, A.C.; Davies, F.E.; Fenton, J.A.; Proffitt, J.A.; Child, J.A.; Smith, G.M.; Morgan, G.J., 1999:
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma

Anonymous, 1998:
Liposomal daunorubicin: new preparation. Kaposi's sarcoma: occasional remission

Welsh, N.; Margulis, B.; Bendtzen, K.; Sandler, S., 1994:
Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide- but not interleukin-1 beta-induced inhibition of glucose metabolism in rat pancreatic islets

Emerson, 2000:
Liposomal delivery of camptothecins

Tari, A.; Khodadadian, M.; Ellerson, D.; Deisseroth, A.; Lopez-Berestein, G., 1996:
Liposomal delivery of oligodeoxynucleotides

Wilkinson, K., 2002:
Liposomal doxorubicin

Porche, D.J., 1996:
Liposomal doxorubicin (Doxil)

Plasswilm, L., 2001:
Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer or head and neck cancer

Simpson, J.K.; Miller, R.F.; Spittle, M.F., 1993:
Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma

Hengge, U.R.; Brockmeyer, N.H.; Baumann, M.; Reimann, G.; Goos, M., 1993:
Liposomal doxorubicin in AIDS-related Kaposi's sarcoma

Kouloulias, V.E.; Dardoufas, C.E.; Kouvaris, J.R.; Gennatas, C.S.; Polyzos, A.K.; Gogas, H.J.; Sandilos, P.H.; Uzunoglu, N.K.; Malas, E.G.; Vlahos, L.J., 2002:
Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial

Grünaug, M.; Bogner, J.R.; Loch, O.; Goebel, F.D., 1998:
Liposomal doxorubicin in pulmonary Kaposi's sarcoma: improved survival as compared to patients without liposomal doxorubicin

Anonymous, 1999:
Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma

Muggia, F.M., 2001:
Liposomal encapsulated anthracyclines: new therapeutic horizons

Chang, H.C.; Flanagan, D.R., 1995:
Liposomal entrapment of suramin(II): interaction of suramin with phospholipids of various chain lengths

Krasnopol'skiĭ, I.M.; Dranov, A.L.; Stepanov, A.E.; Shvets, V.I., 1998:
Liposomal forms of cytostatics in oncology

Kwak, L.W.; Pennington, R.; Boni, L.; Ochoa, A.C.; Robb, R.J.; Popescu, M.C., 1998:
Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity

Anonymous, 1997:
Liposomal formulation of amphotericin B approved for marketing

Betageri, G.V.; Segers, J.; Spaulding, T.C.; Pejaver, S.K.; Brittain, H.G., 1996:
Liposomal formulation of mirfentanil hydrochloride

Mehta, S.C.; Lai, J.C.; Lu, D.R., 1996:
Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy

Ouadahi, S.; Paternostre, M.; André, C.; Genin, I.; Thao, T.X.; Puisieux, F.; Devissaguet, J.P.; Barratt, G., 1998:
Liposomal formulations for oral immunotherapy: in-vitro stability in synthetic intestinal media and in-vivo efficacy in the mouse

Massing, U.; Fuxius, S., 2001:
Liposomal formulations of anticancer drugs: selectivity and effectiveness

Janknegt, R., 1996:
Liposomal formulations of cytotoxic drugs

Iarkov, S.P.; Skopinskaia, S.N., 1999:
Liposomal immunoassay as a method for detecting microorganism antigens and their antibodies

Gianan, M.A.; Kleinerman, E.S., 2000:
Liposomal muramyl tripeptide (CGP 19835A lipid) therapy for resectable melanoma in patients who were at high risk for relapse: an update

Asano, T.; McWatters, A.; An, T.; Matsushima, K.; Kleinerman, E.S., 1994:
Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes

Abraham, E.; Baughman, R.; Fletcher, E.; Heard, S.; Lamberti, J.; Levy, H.; Nelson, L.; Rumbak, M.; Steingrub, J.; Taylor, J.; Park, Y.C.; Hynds, J.M.; Freitag, J., 1999:
Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group

Ollikainen, H.; Lappalainen, K.; Jääskeläinen, I.; Syrjänen, S.; Pulkki, K., 1996:
Liposomal targeting of bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines

Yarosh, D.B.; Both, D.; Brown, D., 2001:
Liposomal ursolic acid (merotaine) increases ceramides and collagen in human skin

Green, S.; Fortier, A.; Dijkstra, J.; Madsen, J.; Swartz, G.; Einck, L.; Gubish, E.; Nacy, C., 1995:
Liposomal vaccines

Sarris, A.H.; Hagemeister, F.; Romaguera, J.; Rodriguez, M.A.; McLaughlin, P.; Tsimberidou, A.M.; Medeiros, L.J.; Samuels, B.; Pate, O.; Oholendt, M.; Kantarjian, H.; Burge, C.; Cabanillas, F., 2000:
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial

Ozpolat, B.; Lopez-Berestein, G., 2002:
Liposomal-all-trans-retinoic acid in treatment of acute promyelocytic leukemia

Poizot-Martin, I.; Giovannini, M.; Rosello, R.; Viallat, J.R.; Sauniere, J.F.; Dalmas, A.M.; Genre, D.; Dhiver, C.; Gastaut, J.A., 1994:
Liposomal-doxorubicin in human immunodeficiency virus-associated Kaposi's sarcoma

Treat, J.; Damjanov, N.; Huang, C.; Zrada, S.; Rahman, A., 2001:
Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel

Fernández B de Quirós, J.; Telenti, M.; Fernández Castro, A.; Mateos, V.; Arnáez Moral, E., 1993:
Liposome amphotericin in the treatment of deep mycoses in patients not severely immunosuppressed. An efficient alternative with low toxicity

Marks, S., 1996:
Liposome battle for antifungal market shifts into high gear

Siminovitch, D.; Chapman, D., 1971:
Liposome bilayer model systems of freezing living cells

Roslaniec, M.; Weitman, H.; Freeman, D.; Mazur, Y.; Ehrenberg, B., 2001:
Liposome binding constants and singlet oxygen quantum yields of hypericin, tetrahydroxy helianthrone and their derivatives: studies in organic solutions and in liposomes

Nagae, I.; Koyanagi, Y.; Ito, S.; Tanabe, Y.; Unezaki, S., 1998:
Liposome drug delivery system for murine neuroblastoma

Ermacora, A.; Michieli, M.; Pea, F.; Visani, G.; Bucalossi, A.; Russo, D., 2000:
Liposome encapsulated daunorubicin (daunoxome) for acute leukemia

Mader, D.; Huang, Y.; Wang, C.; Fraser, R.; Issekutz, A.C.; Stadnyk, A.W.; Anderson, R., 1999:
Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge

Arora, N.; Gangal, S.V., 1999:
Liposome entrapped allergen reduces plasma histamine in sensitized mice

Claassen, D.E.; Spooner, B.S.; Spooner, B.S., 1996:
Liposome formation in microgravity

Langner, M., 1999:
Liposome gene delivery system

Okabayashi, Y.; Ikeuchi, I., 1998:
Liposome immunoassay by long-lived fluorescence detection

Gabizon, A.; Chemla, M.; Tzemach, D.; Horowitz, A.T.; Goren, D., 1996:
Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines

Katsel, P.L.; O'Connell, B.; Mizuno, T.M.; Mobbs, C.V.; Greenstein, R.J., 2001:
Liposome mediated gene transfer into GH3 cells, and rat brain, liver and gut: comparison of different polar or aliphatic domains

Fukasawa, M.; Shimizu, Y.; Shikata, K.; Nakata, M.; Sakakibara, R.; Yamamoto, N.; Hatanaka, M.; Mizuochi, T., 1999:
Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes

Bradley, 2000:
Liposome treatment offers amputation reprieve

Niesman, M.R.; Peyman, G.A.; Miceli, M.V., 1997:
Liposome uptake by human retinal pigment epithelial cells in culture

Shen, M.; Feng, Y.; Ge, B.; Wu, Z.; Zhu, M., 2002:
Liposome-C-erbB2 antisense oligodoxynucleotides in human ovarian cancer cells

Hitz, T.; Luisi, P.L., 2001:
Liposome-assisted selective polycondensation of alpha-amino acids and peptides

Park, J.W., 2002:
Liposome-based drug delivery in breast cancer treatment

Nightingale, S.D.; Saletan, S.L.; Swenson, C.E.; Lawrence, A.J.; Watson, D.A.; Pilkiewicz, F.G.; Silverman, E.G.; Cal, S.X., 1993:
Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients

Rabinovici, R.; Spirig, A.; Abdullah, F.; Phillip, D.R.; Ovadia, P.; Rudolph, A., 2000:
Liposome-encapsulated hemoglobin does not exacerbate endotoxin-induced lung injury

Kleinerman, E.S.; Maeda, M.; Jaffe, N., 1993:
Liposome-encapsulated muramyl tripeptide: a new biologic response modifier for the treatment of osteosarcoma

Teske, E.; Rutteman, G.R., 1993:
Liposome-enhanced tumour therapy in canine mammary gland tumours

Alvarez, M.J.; Echechipía, S.; García, B.; Tabar, A.I.; Martín, S.; Rico, P.; Olaguibel, J.M., 2003:
Liposome-entrapped D. pteronyssinus vaccination in mild asthma patients: effect of 1-year double-blind, placebo-controlled trial on inflammation, bronchial hyperresponsiveness and immediate and late bronchial responses to the allergen

Leff, J.A.; Baer, J.W.; Kirkman, J.M.; Bodman, M.E.; Shanley, P.F.; Cho, O.J.; Ostro, M.J.; Repine, J.E., 1994 :
Liposome-entrapped PGE1 posttreatment decreases IL-1 alpha-induced neutrophil accumulation and lung leak in rats

Kalenik, T.N.; Motavkina, N.S.; Vorob'ev, A.A., 2000:
Liposome-incorporated interferon. The design of liposomal interferon

Nakamura, M.; Tsujii, K.; Sunamoto, J., 1999:
Liposome-induced release of cell membrane proteins from intact tissue epithelium

Düzgüneş, N.; Pretzer, E.; Simões, S.; Slepushkin, V.; Konopka, K.; Flasher, D.; de Lima, M.C., 1999:
Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells

Dass, C.R., 2002:
Liposome-mediated delivery of oligodeoxynucleotides in vivo

Zhang, H-bing., 2003:
Liposome-mediated delivery system in prophylaxis and therapy of malaria

Wink, T.; van Zuilen, S.J.; Bult, A.; van Bennekom, W.P., 1998:
Liposome-mediated enhancement of the sensitivity in immunoassays of proteins and peptides in surface plasmon resonance spectrometry

Kaneda, Y., 1997:
Liposome-mediated gene delivery

Yanagihara, I.; Kaneda, Y.; Inui, K.; Okada, S., 1995:
Liposome-mediated gene transfer

Boasquevisque, C.H.; Mora, B.N.; Boglione, M.; Ritter, J.K.; Scheule, R.K.; Yew, N.; Debruyne, L.; Qin, L.; Bromberg, J.S.; Patterson, G.A., 1998:
Liposome-mediated gene transfer in rat lung transplantation: A comparison between the in vivo and ex vivo approaches

Wang, F.; Xia, X.; Hu, H.; Li, L.; Tian, Y.; Chen, X.; Huang, Q., 2002:
Liposome-mediated gene transfer into retina

Boasquevisque, C.H.; Lee, T.C.; Mora, B.N.; Peterson, D.; Osburn, W.O.; Bernstein, M.; Zhang, W.; Nietupski, J.B.; Scheule, R.K.; Cooper, J.D.; Botney, M.D.; Patterson, G.A., 1997:
Liposome-mediated gene transfer to lung isografts

Schenborn, E.T.; Oler, J., 1999:
Liposome-mediated transfection of mammalian cells

Gatt, S.; Dinur, T.; Dagan, A., 2002:
Liposome-mediated, fluorescence-based studies of sphingolipid metabolism in intact cells

Dutt, M.; Khuller, G.K., 2001:
Liposomes and PLG microparticles as sustained release antitubercular drug carriers--an in vitro-in vivo study

Kaplun, A.P.; Son, L.B.; Krasnopol'skiĭ, I.M.; Shvets, V.I., 1999:
Liposomes and other nanoparticles as drug delivery systems

Bretthauer, R.K.; Welsh, D.W., 2002:
Liposomes and phospholipid binding proteins in glycoprotein biosynthesis

Coutelle, C.; Williamson, R., 1997:
Liposomes and viruses for gene therapy of cystic fibrosis

Singh, A.P.; Khuller, G.K., 1993:
Liposomes as a carrier for mannophosphoinositide antigens of mycobacteria

Taylor, K.M.; Newton, J.M., 1994:
Liposomes as a vehicle for drug delivery

Budai, M.; Szógyi, M., 2002:
Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes

Brandl, M., 2001:
Liposomes as drug carriers: a technological approach

Kshirsagar, N.A.; Gokhale, P.C.; Pandya, S.K., 1995:
Liposomes as drug delivery system in leishmaniasis

Désormeaux, A.; Bergeron, M.G., 1998:
Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection

Clark, A.P., 1998:
Liposomes as drug delivery systems

Hawthorne, M.F.; Shelly, K., 1997:
Liposomes as drug delivery vehicles for boron agents

Delmas-Beauvieux, M.C.; Leducq, N.; Thiaudière, E.; Diolez, P.; Gin, H.; Canioni, P.; Gallis, J.L., 2000:
Liposomes as fatty acids carriers in isolated rat liver: effect on energy metabolism and on isolated mitochondria activity

Popescu, C.; Durbaca, S.; Ivanov, D., 2002:
Liposomes as immunological adjuvants for tetanus vaccine

Aramaki, Y., 2000:
Liposomes as immunomodulator--inhibitory effect of liposomes on NO production from macrophages

López, O.; Cócera, M.; Walther, P.; Wehrli, E.; Coderch, L.; Parra, J.L.; de la Maza, A., 2000:
Liposomes as protective agents of stratum corneum against octyl glucoside: a study based on high-resolution, low-temperature scanning electron microscopy

Harrington, K.J.; Lewanski, C.R.; Stewart, J.S., 2000:
Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development

Harrington, K.J.; Lewanski, C.R.; Stewart, J.S., 2000:
Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development

Eckstein, M.; Barenholz, Y.; Bar, L.K.; Segal, E., 1997:
Liposomes containing Candida albicans ribosomes as a prophylactic vaccine against disseminated candidiasis in mice

Waters, R.E.; White, L.L.; May, J.M., 1997:
Liposomes containing alpha-tocopherol and ascorbate are protected from an external oxidant stress

Dass, C.R.; Walker, T.L.; Burton, M.A., 2002:
Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency

Skalko-Basnet, N.; Pavelic, Z.; Becirevic-Lacan, M., 2001:
Liposomes containing drug and cyclodextrin prepared by the one-step spray-drying method

Neelamegham, S.; Matta, K.L., 2002:
Liposomes containing ligands. Binding specificity to selectins

Hirnle, P., 1997:
Liposomes for drug targeting in the lymphatic system

Laverman; Boerman; Oyen; Dams; Storm; Corstens, 2000:
Liposomes for scintigraphic detection of infection and inflammation

Boerman, O.C.; Oyen, W.J.; Corstens, F.H.; Storm, G., 1999 :
Liposomes for scintigraphic imaging: optimization of in vivo behavior

Prüfer, K.; Sternberg, B., 1994:
Liposomes in medicine. An assessment of current status

Desmettre, T.; Mordon, S.; Soulie, S.; Devoisselle, J.M.; Weisslinger, J.M., 1996:
Liposomes in opthalmology. Review of the literature

Novikova, R.I.; Chernyĭ, V.I.; Stefanov, A.V.; Akhlamova, I.I., 1993:
Liposomes in the combined treatment of patients with chronic obstructive bronchitis

Alfonta, L.; Singh, A.K.; Willner, I., 2001:
Liposomes labeled with biotin and horseradish peroxidase: a probe for the enhanced amplification of antigen--antibody or oligonucleotide--DNA sensing processes by the precipitation of an insoluble product on electrodes

Kurohane, K.; Namba, Y.; Oku, N., 2001:
Liposomes modified with a synthetic Arg-Gly-Asp mimetic inhibit lung metastasis of B16BL6 melanoma cells

Joshi, M.R.; Misra, A.N., 2000:
Liposomes of terbutaline sulphate: in vitro and in vivo studies

Takiguchi, K.; Nomura, F.; Inaba, T.; Takeda, S.; Saitoh, A.; Hotani, H., 2002:
Liposomes possess drastic capabilities for topological transformation

Suntres, Z.E.; Shek, P.N., 1999:
Liposomes promote pulmonary glucocorticoid delivery

Zawada, Z.Z.; Michnik, A.; Drzazga, Z., 2002:
Liposomes with a double bilayer--a study on stability

Bakker-Woudenberg, I.A.; Lokerse, A.F.; ten Kate, M.T.; Mouton, J.W.; Woodle, M.C.; Storm, G., 1993:
Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue

Gregoriadis, G., 1993:
Liposomes, a tale of drug targeting

Ravaoarinoro, M.; Toma, E., 1993:
Liposomes, in the treatment of infections

Cortesi; Nastruzzi, 1999:
Liposomes, micelles and microemulsions as new delivery systems for cytotoxic alkaloids

Mönkkönen, J., 2002:
Liposomes--an invaluable tool in bisphosphonate research

Szulc, J.; Dudzik, M.; Woyczikowski, B.; Sznitowska, Młgorzata.; Janicki, Sław., 2002:
Liposomes--therapeutic progress and technological problems

Hope, M.J.; Kitson, C.N., 1993:
Liposomes. A perspective for dermatologists

Ghosh, S.; Bell, R., 2002:
Liposomes. Applications in protein-lipid interaction studies

Gil-Monreal, M.; Fernandez-Escalada, M.; Royuela, M.; Zabalza, A., 2018:
An aerated axenic hydroponic system for the application of root treatments: exogenous pyruvate as a practical case

Banerjee, R., 2001:
Liposomes: applications in medicine

Brisson, M.; Huang, L., 2001:
Liposomes: conquering the nuclear barrier

Bricaire, F., 1999:
Liposomes: promising perspectives

Barenholz, 2000:
Liposomology

Schwartz, B.; Benoist, C.; Abdallah, B.; Scherman, D.; Behr, J.P.; Demeneix, B.A., 1995:
Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio

Khopade, A.J.; Shelly, C.; Pandit, N.K.; Banakar, U.V., 2000:
Liposphere based lipoprotein-mimetic delivery system for 6-mercaptopurine

Růzek, V.; Procházka, J., 1993:
Lipostat in the treatment of hyperlipoproteinemia

Yamamoto, H.; Asoh, M.; Murakami, H.; Kamiyama, N.; Ohta, C., 1998:
Liposteroid (dexamethasone palmitate) therapy for West syndrome: a comparative study with ACTH therapy

Yoshikawa, H.; Ikeda, S.; Watanabe, T., 1998:
Liposteroid therapy in a case of early infantile epileptic encephalopathy with suppression burst

Lawrence, N., 2000:
Liposuction Council bulletin

Anonymous, 1988:
Liposuction and other cosmetic surgery: where do they fit; what are the risks for hospitals?

D.Rocha, R.P., 2001:
Liposuction and scar placement

Håland, E.; Lund, A.; Ursin, H., 1994:
Liposuction and suicide

Jacob, C.I.; Berkes, B.J.; Kaminer, M.S., 2000:
Liposuction and surgical recontouring of the neck: a retrospective analysis

Price, M.F.; Massey, B.; Rumbolo, P.M.; Paletta, C.E., 2001:
Liposuction as an adjunct procedure in reduction mammaplasty

Matarasso, A., 2000:
Liposuction as an adjunct to a full abdominoplasty revisited

Gray, L.N., 1998:
Liposuction breast reduction

Brorson, H.; Svensson, H., 1998:
Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone

Pacik, P.T., 2001:
Liposuction fat versus total aspirate: a time for more precise terminology

Hang-Fu, L.; Marmolya, G.; Feiglin, D.H., 1995:
Liposuction fat-fillant implant for breast augmentation and reconstruction

Regidor, P.A.; Schmidt, M.; Walz, K.A.; Regidor, M.; Winkler, U.H.; Bier, U.W.; Schindler, A.E., 2001:
Liposuction for "body contouring" in gynecology

Berenguer, B.; de la Cruz, L.; de la Plaza, R., 2000:
Liposuction in atypical cases

Markey, A.C., 2001:
Liposuction in cosmetic dermatology

de Jong, R.H., 2001:
Liposuction in medical offices

Flageul, G., 1994:
Liposuction in the plastic surgery of the abdomen. Focus on technical aspects and indications

Ilhan, H.; Tokar, B., 2002:
Liposuction of a pediatric giant superficial lipoma

Oliver, D.W.; Inglefield, C.J., 2002:
Liposuction of haematoma

Langdon, R.C., 2000:
Liposuction of neck and jowls: five-incision method combining machine-assisted and syringe aspiration

Illouz, Y.G., 1999:
Liposuction of the abdomen

Lillis, P.J., 1999:
Liposuction of the arms

Lillis, P.J., 1998:
Liposuction of the arms, calves, and ankles

Matarasso, S.L., 1999:
Liposuction of the chest and back

Chamosa, M., 1997:
Liposuction of the kneecap area

Karacalar, A.; Ozcan, M., 1998:
Liposuction of the kneecap area under tourniquet: a superdry procedure

Lillis, P.J., 1999:
Liposuction of the knees, calves, and ankles

Bernstein, G., 1999:
Liposuction of the thigh

Castrow, F.F., 2003:
Liposuction procedures: how, not where

Brorson, H.; Svensson, H.; Norrgren, K.; Thorsson, O., 1999:
Liposuction reduces arm lymphedema without significantly altering the already impaired lymph transport

Ascari-Raccagni, A.; Baldari, U., 2000:
Liposuction surgery for the treatment of large hematomas on the leg

Frick, A.; Hoffmann, J.N.; Baumeister, R.G.; Putz, R., 1999:
Liposuction technique and lymphatic lesions in lower legs: anatomic study to reduce risks

Vanwijck, R., 1993:
Liposuction to radiologist's rescue

Mole, B., 1996:
Liposuction using a rotary cannula. Technical note

Shiffman, M.A., 2000:
Liposuction with standing technique

Shuter, D.; Drourr, N.R., 1999:
Liposuction with standing technique: the true lipo "sculpture"

Lehnert, 2000:
Liposuction, yes--but not for overweight patients